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 Defensins comprises a large family of antimicrobial peptides and is classified in 
to three different sub-families (α, b and q defensins). Most of them are cationic, small, 
amphiphilic with fewer than 100 amino acids showing activity against vast number of 
deadly microorganisms like bacteria, fungi and enveloped viruses. Defensins are seen in 
all humans, animals, plants and insects. These peptides are known to display both 
cationic and hydrophobic surfaces on their structures which are considered to be the 
prerequisite for their ability to disrupt bacterial membranes.  Among all the human 
defensins, Human Beta Defensin - 3 (HBD-3) is known to exhibit many interesting 
behaviors including its unusually high positive charge (+11), broad spectrum of activity 
with comparatively low salt sensitivity etc. HBD-3 is potent against Escherichia coli, 
Pseudomonas aeruginosa, Klebsiella pneumonia, Staphylococcus  aureus, Streptococcus 
pyogenes, Enterococcus faecium, Streptococcus pneumoniae, Staphylococcus carnosus, 
and many others. It also has low lytic activity on the human erythrocytes and shows no 
cytotoxic effect against human cells. The enormous number of investigations regarding 
the activity and selectivity of HBD-3 shows that the membrane induced helix in HBD-3 
might be important for its selection of bacterial membranes. In addition the correlation of 
activities with the structural changes of HBD-3 demonstrates the importance of the 
overall positive charge distribution and the hydrophobicity of HBD-3 on its activity and 
cytotoxicity. There are many findings on various aspects of HBD-3 but still only little is 
known about the influence of the structural properties (most importantly the S-S linkages) 
of the b-defensin on its direct interactions with eukaryotic membranes. The NMR 
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structure of the micelle bound HBD-3 peptide is not available to describe the influence of 
its conformation on the activity.  
In order to explore the importance of the three dimensional structure of HBD-3 on 
its activity and selectivity, we have mutated all its six cysteine residues to other amino 
acids. The mutant HBD-3 (named as Def-A) was expressed in E. coli and its activity, 
binding, structure and dynamics were characterized. Our experiment provides data on the 
structure and dynamics of HBD-3 when all its cysteine residues are mutated and 
subjected to different model membranes. This study also addressed the importance of the 
defensin fold on the selectivity, potency and behavior of this peptide based on its 
structure. The mutant has comparable activity with the wild type HBD-3 at low salt 
concentrations and is active against all the tested Gram-positive bacteria (Bacillus 
megaterium IAM 13418 T and Staphylococcus aureus ATCC 25923) and Gram-negative 
bacteria (Escherichia coli ATCC 25922 and Psuedomonas auroginosa ATCC 27853). 
When subjected to vesicles like POPG or to micelles like SDS and DPC, Def-A is 
changed from a random coil structure to an ordered helical form. We have determined the 
structure of Def-A in SDS micelle and found that it is folded into two distinct helices 
separated by a proline kink. We propose that the long N-terminal helix with many 
hydrophobic residues is inserted inside the micelle while the C-terminal helix with one 
large positive charge patch is located outside the micelle and interacts with the charged 
head groups of the micelle. The model is supported by NMR relaxation and H/D 
exchange data.  For the purpose of studying the selectivity/specificity of the peptide, the 
mutant was treated with different types of lipids that can mimic the different outer 
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membranes of cells. The non-toxic nature of the mutant is shown by its inability to bind 
with the zwitterionic POPC vesicles that mimic mammalian cell membrane. The affinity 
of Def-A towards LPS molecules (the major constituent of gram-negative bacteria cell 
wall) was shown by ITC and NMR experiments. The LPS induced structure of Def-A 
provides a basis for the design of peptide that can have endotoxin neutralization 
properties. In conclusion, our results indicate that the antimicrobial activity and 
selectivity of human beta defensins are determined not only by the numbers of positively 
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CHAPTER 1: Introduction  
 The entire research in this project involves understanding of the structure-based 
functions of Human beta defensins-3, a highly potent antimicrobial peptide, and to 
provide valuable information for designing peptides for therapeutic usages. In order to 
emphasize the importance of this work, this thesis begins with a brief introduction 
explaining the discovery and the on-going research in the field of antimicrobial peptides. 
This chapter describes all the general discussions involved in these studies followed by 
the need for this particular project. 
1.1 Antimicrobial peptides (AMPs) 
  Antimicrobial peptides, as the name indicates, are peptides involved in killing 
pathogenic microorganisms or preventing their entry into their host. The pathogens 
include Gram-positive and Gram-negative bacteria, mycobacteria, some enveloped 
viruses, fungi and also transformed or cancer cells. The antimicrobial peptides are found 
to be involved in the defense mechanism of many living beings. The innate immune 
system actually remains as a physical barrier by producing antimicrobial peptides as 
deterrents to prevent the entry of invading microorganisms. This ability of the innate 
immune system to recognize and neutralize the microbial invaders is highly related to the 
efficacy of the host defense system for any living being. The fundamental differences 
among the antimicrobial peptides depend on the source organism and their targets. 
Researchers are interested in working with these peptides as they found these peptides to 
have a high potential to become therapeutic agents and act as alternatives to commercial 
antibiotics. The research in antimicrobial peptides was considered to be one of the hot 
topics. These peptides also exert their bactericidal activities much faster then common 
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bacteriostatic antibiotics. Understanding the mechanism and structure activity 
relationship for these peptides is believed to be essential to generate a highly specific and 
potent antimicrobial peptide with low cytotoxicity.  
1.1.1 Discovery and the timeline 
The study on these antimicrobial peptides started when bioactive components 
were identified from secretions, blood and tissues during the end of nineteenth century 
(Skarnes et al., 1957). Later, by the beginning of the twentieth century many different 
antimicrobial peptides were isolated from several sources and studied. The first identified 
bacteriolytic substance was the one isolated from the nasal mucus (later named as 
lysozyme) while some other basic proteins or polypeptides with antimicrobial activities 
were also noted. During that time the activity of these molecules was reported as due to 
purely electrostatic interaction with the cell nucleoproteins or negatively charged surface 
constituents of bacteria and viruses (Skarnes et al., 1957). The researches made clear that 
these peptides are the so called aberrant agents that tend to kill or slow down the growth 
of the invading bacteria or microorganism either in the innate or adaptive manner. Each 
of them independently isolated and purified several antimicrobial agents from different 
sources including insect cecropins, amphibian magainins and mammalian defensins 
(Steiner et al., 1981; Ganz et al., 1990; Zasloff et al., 1987). Figure 1.1 shows the 









































Figure 1.1: Diagram showing the time line of selective scientific studies on antimicrobial 





1.1.2 Classifications of AMPs 
From the day of discovery enormous number of antimicrobial peptides have been 
isolated and characterized from species after species. These large numbers of 
evolutionarily conserved peptides were classified according to their, amphiphilic 
structure and amino acid composition. Their classification, expression sites and 
representative examples are described below. 
1.1.2.1 Anionic peptides 
 These are short peptides (< 900 Da) classified due to their overall anionic charges. 
They all generally require zinc as a cofactor for exhibiting their antimicrobial activity. 
They were isolated from the surfactant extracts of bronchoalveolar lavage fluids and 
airway epithelial cells (Brogden et al., 1996, 1998 and 1999) and found active against 
both Gram-positive and Gram-negative bacteria. 
Examples: 
• Maximin H5 (amphibians)  
• Dermicidin (humans) 
• Glutamic and aspartic acid rich peptides (sheep, cattle and humans) 
1.1.2.2 Small cationic peptides  
 These are small linear peptides with positive charges. They lack cysteine residues 
and generally found to be unstructured. But when subjected to sodium dodecyl sulfate, 
phospholipids vesicles and lipid A molecules, either all or part of their amino acid 
sequences are converted into alpha helices. The increase in the helical content is proven 




• Cecropins (A), andropin, moricin, ceratotoxin and melittin from insects, 
• Cecropin P1 from Ascaris nematodes148, 
• Magainin (2), dermaseptin, bombinin, brevinin-1, esculentins and buforin II from 
amphibians, 
• Cathelicidin derived peptides including LL37 (humans), 
• CAP18 (rabbits), 
• MSI AMPs derived from magainins,  
1.1.2.3 Cationic peptides rich in some specific amino acid groups  
 These are also cationic peptides but they are distinct from the normal cationic 
peptides as they are rich in particular residues like proline, arginine, tryptophan or 
phenylalanine. They also lack cysteine residue and hence are either linear or extended 
coils.  
Examples; 
• Bactenecins (cattle) and PR-39 (pigs); both are rich in proline and arginine, 
• Prophenin (pigs); rich in proline and phenylalanine, 
• Indolicidin  (cattle); rich in tryptophan. 
1.1.2.4 Disulfide bonded anionic and cationic peptides 
 Although with different overall charges, peptides which can form stable b sheets 
due to the presence of one to four disulfide bridges are classified into this general 
category. These are further classified based on the number of cysteine residues and other 
conservatory residues they have. The major class of AMP, defensins, falls under this 
category which itself is a diversified class and will be discussed elaborately in the next 




• Brevinins; peptides with 1 disulfide bond 
• Protegrin (pigs) and tachyplesins (horseshoe crabs); Peptides with 2 disulphide bonds 
• Alpha, beta (insect, humans and cattle) and theta defensins (rhesus monkey); peptides 
with 3 disulfide bonds 
• Drosomycin (fruit flies) and plant defensins; peptides more than 3 disulphide bonds 
1.1.2.5 Fragments of larger proteins 
 Those fragments of large proteins leading to anionic or cationic peptides that 
show antimicrobial activities are classified into this group. The exact significance of 
these peptides is still unclear but their antimicrobial properties fall into the same category. 
Examples; 
• Antimicrobial domains from bovine α-lactalbumin, human haemoglobin, lysozyme and 
ovalbumin. 
• Lactoferricin from lactoferrin. 
1.1.3 The family of defensins 
 Defensins are wide spread and involved in the defense mechanisms of many 
organisms (hence the name defensins), and form the major class of AMPs next to the 
cathelicidins. Cathelicidins differ from defensins in their structure and evolution (Zenetti 
et al., 1995; Lehrer et al., 2002). Defensins are generally present in all living beings 
including insects, animals and plants. They are characterized as peptides having b-sheet 
rich fold with a six disulfide linked cysteine framework (whereas plant defensins have 
eight cysteine residues). Defensins are found to have fewer than 50 amino acids and 
hence their molecular weights are ranged between 3 to 6 kDa. Based on sequence length, 
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spacing between the cysteines and their disulfide connectivity patterns, they are further 
divided into three subfamilies: a, b and q defensins (Figure 1.2). Basically the peptides 
with S-S linkages between the cysteins at positions 1-6, 2-4 and 3-5 are classified as a 
and those with linkages at 1-5, 2-4 and 3-6 are classified as b (here the number depicts 
the positioning of the cysteine regardless of the amino acid length between them). The q 
defensins are classified due to their cyclic nature maintained by three disulfide bonds. 
The cationicity of defensins vary widely from +2 to +11 but they are generally known to 




Figure 1.2: Sequences and disulfide connectivites of defensins. Representative 
peptides from a (HNP-1), b (HBD-3) and q (RTD-1) defensin family showing their 





Despite of having low sequence homology the tertiary structures of a and b 
defensins are very similar, both having three stranded antiparallel b-sheets with the 
distinctive “defensin fold” but a short N-terminal alpha helix is seen only in human beta 
defensins. The q defensins are dissimilar to a and b by having a circular backbone 
consisting of 18 amino acids (Figure 1.2). Even though the disulfide connectivities for 
some peptides are a mere assumption, all mammalian defensins have been proved to have 
three disulfide bonds. Structures of several representatives of these sub-families have 
been solved by NMR and X-ray crystallography (Hoover et al., 2000 and 2001; Schibli et 
al., 2002; Hill et al., 1991; Szyk et al., 2006). Though the roles of S-S linkages are not 
clear in their biological activities they are shown to provide the stability for the b strands 
and also believed to prevent these peptides from peptidase digestions. There are models 
and experimental proofs to demonstrate the possibility of dimer or oligomer formation 
(Pardi et al., 1992; Wimley et al., 1994) for some of the peptides but their significance in 













Figure 1.3: Ribbon diagrams of Selected Defensins. A comparison of structures of 
different types of defensins (A) Human Neutrophil Peptide 3 (Dimer), (B) Insect defensin 







1.1.3.1 Expression of defensins 
As stated before, defensins are widely expressed in almost all mammals, birds, 
invertebrates and plants. Some recent reports show the presence of defensin even in the 
ebony-cup fungi (Schnorr et al., 2003). In mammals, the alpha defensins are generally 
expressed in the neutrophils and paneth cells to different extent in different species 
(Huttner et al., 1999). Whereas the beta defensins could be isolated from several sources 
including epithelial cells, blood plasma and urine (Huttner et al., 1999; Schröder et al., 
1999). In humans, alpha defensins are mainly expressed in paneth cells and granulocytes 
within the epithelium in small intestine and hence they are also called enteric defensins 
(Huttner et al., 1999). The sequences of many peptides isolated from leukin, phagocytin 
and CAP molecules of rabbit and human were reported in 1985 (Selsted et al., 1985a and 
1985b) and then recognized as natural peptide antibiotics and renamed as defensins 
(Ganz et al., 1985). 
The expression level and the identity of different classes of defensins differ 
among each species. Until now both alpha and beta classes have been found in humans 
and rodents whereas in rabbits and guinea pigs, only alpha defensins have been reported 
to be present in their leukocytes (Ganz et al., 1994). In cattle, sheep and pigs, only beta 
defensins have been reported so far (Huttner et al., 1999). The expression of q defensins 
has been shown in neutrophils and monocytes of only the rhesus monkeys. 
1.1.3.2 Expression of Human Beta Defensins  
The human beta defensins (HBDs) are either constitutively expressed or induced 
upon inflammatory or pathogen derived stimuli mostly in the epithelial tissues. HBD-1 is 
found to be expressed in epithelial tissues of small intestine, pancreas, kidney, prostate, 
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testis, vagina, ectocervix and endocervix uterus, fallopian tubes, placenta and the thymus. 
Keratinocytes associated inflammatory skin lesion or psoriasis vulgaris also has high 
level expressions of HBD-1. HBD-2 was first purified from psoriatic skin lesions and 
later its expression was found in keratinocytes, gingival mucosa and tracheal epithelium. 
Same as HBD-1 and HBD-2, the peptide HBD-3 was also purified initially from the 
psoriatic skin lesions but later the expression of HBD-3 was confirmed in many sites 
which include lung epithelial cells, submandibular salivary glands, gingiva-tongue, 
buccal mucosa, skin, trachea, tongue, uterus, pharynx, kidney, thymus, colon, and 
placenta. Expression of two more peptides, HBD-4 and HBD-5, in the epithelial cells has 
been confirmed and characterized at the mRNA level and also chemically synthesized for 
analysis (Garcia et al., 2001). According to defensins knowledgebase 
(http://defensins.bii.a-star.edu.sg), there are 363 defensin entries with information 
regarding sequence, structure and activity.  
1.1.4 Human beta defensin-3 
Among all the human defensins, HBD-3 is known to exhibit many interesting or 
remarkable behaviors like the high positive charge (+11), broad spectrum of potent 
activities in a salt resistant manner, low lytic activity on the human erythrocytes and no 
cytotoxic effect against various human cells (Harder et al 2001). This peptide consists of 
45 amino acid residues whose structure shows amphiphilic nature (figure 1.4) and is 
known to be the most potent peptide among all the human defensins identified so far 
(Dhople et al., 2006). Its activity has been shown against many Gram-positive and 
negative bacteria, fungi and enveloped viruses in vitro and proven to be salt resistant 
towards some Gram-positive bacteria.  
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HBD-3 is known to exist as a dimer in solution (but the direct influence of the 
dimeric form on biological activity is still unclear). It has a three stranded anti-parallel b-
sheet along with one short helical segment at the N-terminus. The antimicrobial activity 
of HBD-3 is due to existence of the amphiphillic structure and determined by the extent 
of distribution of cationic and hydrophobic regions on the peptide surface (Kluver et al., 
2005). Even though little is known about the influence of the structural properties of the 
b-defensin on its interaction with eukaryotic membranes (Schneider et al., 2005), the 
presence and positioning of S-S bonds and N-terminal sequence variation are shown to 
have a marginal effect on its activity (Kluver et al., 2005). In contrast to the antimicrobial 
effect, the chemotactic mediated activity is clearly susceptible to changes in S-S 
arrangement (Wu et al., 2003). The exposed interface area with the positively charged 
residues and hydrophobic patches might be important for the peptide to selectively target 



















 Figure 1.4: Primary sequence of HBD-3 showing the helix and beta sheet regions   









1.2 Biological properties of defensins  
1.2.1 Antimicrobial activity 
Most of antimicrobial peptides when isolated show in vitro activity against 
bacteria and fungi when tested at low ionic concentrations at physiological pH. The 
activity of these peptides in vivo is considered to be complex due to the involvement of 
many biological processes inside the living system. For instance, our innate immune 
system has the ability to quickly recognize the invading microbes mainly by binding of 
pathogen associated molecular patterns to the Toll-like receptors (TLR) and other 
recognition molecules on the host cells. After the recognition step, an acute antimicrobial 
response is generated by the recruitment of inflammatory leukocytes for the production of 
antimicrobial substances like defensins by the affected epithelia. The host cellular 
response includes the synthesis and mobilization of these peptides that are capable of 
directly killing a variety of pathogens. Different antimicrobial peptides have different 
modes of action that include membrane disruption followed by cell leakage, interference 
with metabolism, and cytoplasmic component targeting. The mode of action for cationic 
peptides is believed to be through the electrostatic interaction of their cationic surfaces 
with the anionic membrane of bacterial cells, followed by interaction of their 
hydrophobic residues with the membrane components to finally disrupt the target cell. To 
be highly potent, a defensin peptide should have a proper balance between its positive 
charge and hydrophobic residues (Kluver et al., 2005). The three common modes of 





1) Toroidal Pore model  
In this model (Figure 1.5A) the attached peptides aggregate and induce the lipid 
monolayers to bend continuously through the pore so that the water core is lined by both 
the inserted peptides and the lipid’s hydrophilic head groups. 
2) Carpet model 
In this model (Figure 1.5 B), the peptides disrupt the membrane by orienting 
parallel to the surface of the lipid bilayer by forming an extensive layer or carpet.  
2) Barrel-stave model  
In this model (Figure 1.5 C), the attached peptides aggregate and insert into the 
membrane bilayer so that the hydrophobic peptide regions align with the lipid core region 
and the hydrophilic peptide regions forming the interior region of the pore. (For all the 
models hydrophilic regions of the peptide are colored red and hydrophobic regions are 
colored blue). 
Although these three models differ in the mode of binding of peptides, they all 
show that electrostatic interactions are the common initial phase of antimicrobial action. 
This electrostatic attraction is considered to be important for the selectivity of these 
peptides as the cationic peptides get attracted to the anionic phospholipids bilayer 
membrane of the bacteria and not to the zwitterionic membrane in the case of human 
cells. The interaction followed by aggregation to deplete the membrane surface is 
generally accepted as the mechanism of action for most of these peptides. But whether 








Figure 1.5: Proposed models for the membrane disruption of antimicrobial peptides. 
(A) Toroidal pore model (B) carpet model, (C) Barrel Stave model and (D) Electron 










1.2.2 Chemotactic activity  
Apart from the usual antimicrobial behavior many of these peptides also show 
cytotoxic effects on the eukaryotic cells.  
1.3 The unresolved problems of HBD-3 
The highly potent and unique activity of HBD-3 makes its study most interesting. 
The structure activity relationship of the HBD-3 and its analogues was studied already by 
using synthetic derivatives having different charge and varying disulfide bonds and 
overall hydrophobicity (Kluver et al., 2005). Researchers have shown recently that the 
activity of the peptides is mostly governed by the distribution of positively charged and 
hydrophobic residues whereas the presence of cysteine residues and the position of the 
disulfide bonds do not play any major role in their activity (Kluver et al., 2005). However 
some other groups have demonstrated that the presence of disulfide bonds are important 
for the chemotactic activity of the defensins (Wu et al., 2003) as defensins are known to 
be chemotactic agents for monocytes and T cells in mammals. The interaction between 
defensin and its target has been studied using phospholipid vesicles and the disruption 
was shown to be very much dependent on the membrane lipid composition. There are 
many reports regarding the salt resistant nature of HBD-3 (Harder et al., 2001; Garcia et 
al., 2001; 2001a FASEB) as compared to other human defensin which are all salt 
sensitive, but currently there is no report to address the reason for this kind of activity. 
Only little is known about the dependence of antimicrobial and cytotoxic activities of 





1.4 Rationale behind the design of defensin mutations 
  According to the defensins knowledgebase there are about 363 defensin entries 
with information regarding sequence, structure and activity. The identification and study 
of these peptides were mainly focused on improving their therapeutic properties and on 
utilizing them against pathogens that are resistant to antibiotics. Despite the significant 
progress made in the past, the structure-function relationships for the target specificity or 
selectivity of these defensins are largely unexplored. The sequence specific activity and 
the structural determinants in the human defensins that govern a variety of biological 
functions and mechanisms of their action continue to be poorly understood. The 
significance of the disulfide bonds in all the defensins is not resolved till now even 
though researchers have shown that the presence or absence of the disulfide pairs has 
only marginal changes in their potencies. Defensins are a major field of interest for many 
researchers around the world. Every defensin has its own specific activities in both innate 
and adaptive modes of antimicrobial action. In vivo and in vitro activities are affected by 
the salt concentration and magnitude of the inhibition depends on the type of peptide and 
its target. Differentiating their specificities to address why physiological salt 
concentrations, serum and others affect the activities of antimicrobial peptides is most 
important in order to develop a therapeutic peptide. Thus improving an antimicrobial 
peptide for therapeutic purposes is one of the major interests for many researchers. Hence, 
studies in understanding the exact mechanism of action against the pathogens and roles in 






Table 1.1: Alignment of the primary sequences of various mutants and the wild type 





In order to understand the sequence specific activities of these peptides various 
mutations were designed and compared with the wild type peptides for the activity and 
toxicity. Table 1.1 shows various designed HBD-3 analogues and the comparison of their 
activities and toxicities. 
1.5 General Methods for Characterizing Antimicrobial Peptides 
 Today majority of the researchers are generally focused on improving the potency 
and selectivity of antimicrobial peptides and finally modify them into a therapeutic drug. 
For achieving this goal, the study on antimicrobial peptides needs a detailed 
understanding of all its characteristics to explain clearly their level of activity and toxicity. 
Most importantly, the possible three-dimensional conformational changes occurring in 
antimicrobial peptides when they are in action might be able to explain their target 
specificity. The next few sessions will briefly describe the available bio-physical methods 
that can be used for the general characterizations of antimicrobial peptides which are also 
applicable for normal peptides/proteins.  
1.5.1 Bio-assay techniques 
 The potency of an AMP is typically measured by its concentration required to 
inhibit a bacterial agent or other microbes. The concentrations which depict the activity 
or toxicity level of a peptide can be determined using many in vitro assay techniques. 
Different techniques can be used to determine different representations of the potency, 
e.g. the minimum inhibitory concentrations (MIC), lethal concentration (LC50 or LC90) or 
lethal dose (LD). Hancock’s microdilution method is one of the most commonly used 
method and other studies also describe the usage of radial diffusion assay which is 
described below.  
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1.5.1.1 Micro-dilution assay 
 This method, developed by Hancock and coworkers, determines the minimum 
concentration required to inhibit the visible growth of the microbe under study. The 
technique is based on the incubation of with a known cell count (~ 5x105) in a 96 well 
plate at 37 °C overnight with different concentrations of a peptide and later identifying 
the particular concentration at which there is no growth. The LC50 or LC90 which is 
defined as the lethal concentration for the death of 50 % or 90 % of the bacteria 
population can also be determined by spreading a known volume of the test solution onto 
agar plates and counting the colonies after incubation. In general practice, the bacteria 
grown until the mid-log phase would be incubated with different concentrations of 
peptides at 37 °C for two to three hours. After the incubation, several dilutions would be 
made from the original solutions and then spread over LB agar plates for further 
incubation up to 14 hours until bacterial colonies are visible. Depending upon the 
bactericidal strength of the peptides, the number of surviving colonies will vary and 
hence this is considered as a reasonable approach to determine the LC value of any 
antimicrobial peptide.  
1.5.1.2 Radial diffusion assay 
 Radial diffusion assay is also used by some researchers as it is comparatively 
easier than any other available methods used to study the activity of antimicrobial 
peptides. This method is generally used for measuring the susceptibility of the microbes 
to peptides. It involves the measurement of the diameter of the clear zone containing the 
peptides added for inhibiting the growth of the bacterial incubated agar plate. There are 
two ways of performing this method; 1. Piercing uniform sized holes in the agar plate and 
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adding the peptide sample into it. 2. Impregnating paper discs soaked with peptide and 
transferring them onto the surface of the plates for further incubation. Both ways give rise 
to very similar results and the minimum inhibitory concentration can be calculated by 
subtracting the zonal length from the actual calculated length. 
1.5.2 Biophysical techniques 
 Antimicrobial assay techniques can help us to determine the potency level and the 
selectivity of AMPs but the reasoning for their behavior can only be obtained by 
performing several other biophysical studies. The basic biophysical techniques start from 
the determination of primary (amino acid sequence) structures followed by the study of 
secondary conformations under different solution conditions and finally resolving the 
tertiary structure using NMR or X-ray. The determination of the binding affinities and 
specific binding sites for the peptides/proteins are carried out to further investigate the 
structure function relationships. The following sessions briefly describe the basic 
techniques used for these studies. 
1.5.2.1 CD spectroscopy- Secondary and tertiary structural studies 
 Since 1960s, after the commercialization of the circular dichroism (CD) 
instrument, many polypeptides, proteins, nucleic acids etc. were studied for their 
secondary structure analyses. It is a type of absorption spectroscopy that can provide 
information on the structure of many molecules based on their optical properties. The CD 
spectrum is a measurement between the minute differences in absorption of the left and 
right circularly polarized light by the sample which is generally kept in quartz cuvette.  
For any protein or a peptide, the circular dichroism can clearly show low resolution 
secondary structure or the transitions of conformation upon treatment with agents that can 
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affect their structures. The changes in conformation due to ligand binding, pH, 
temperature or solvent inductions are commonly studied using CD. In general, the 
absorptions by any amide linkage will be due to the electronic transitions between n-p* at 
210-230 and p-p* at 180-200 nm. But in case of polypeptides, the exact absorptions are 
affected by many factors like hydrogen bonds, the secondary or tertiary orientations of 
the amide bonds or the length of the conjugation of nitrogen lone pair electrons with that 
of the carbonyl electrons. Thus one can differentiate between the α-helix, β-sheet, β-turn 
or unstructured regions of proteins as they all show their characteristic CD spectra. 
Briefly, the α-helical proteins are identified by their negative absorptions at 222 and 208 
nm and positive absorption at 192 nm, whereas β-sheets by their negative absorption at 
216 nm and a positive one at 195 nm. β-turn like structures can be identified by their 
weak signals between 220-230 nm and strong signal at 180-190 nm with a positive signal 
at 205 nm. If a CD spectrum does not show any of the above characteristics but a single 
negative signal below 200 nm, then it should be a randomly coiled protein. The presence 
or absence of disulfide bonds can also be detected by recording CD spectra at the far UV 
region with a ten-fold increase in the protein concentration. Hence the information about 
tertiary structure can also be acquired from this study. As already mentioned, the ability 
or propensity to form amphipathic helical structures upon treatment with model 
membranes or helix inducing agents is considered to be an important property for an 
antimicrobial peptide. CD spectrometer should be an important instrument for analyzing 





1.5.2.2 Fluorescence spectroscopy- study of tertiary structural changes  
 Similar to circular dichroism, the fluorescence spectroscopy is also a non-
destructive method for analyzing the structural changes of proteins/peptides. The most 
fascinating aspect in fluorescence is that it is highly sensitive to even small tertiary level 
conformational changes occurring in proteins or peptides. It works on the principle that 
when a photon of energy hits a molecule, its electron at the lowest singlet state gets 
excited to one of the higher energy states and without any further delay the electron 
relaxes back into a semi-excited state emitting an energy equivalent to that particular 
energy gap. As this energy gap is influenced by the micro environment around the 
molecule, the emitted fluorescence at different experimental conditions give general 
details that can be applicable to the whole molecule. 
 Out of the twenty amino acids only three aromatic amino acids (Tryptophan; W, 
Tyrosine; Y and Phenylalanine; F) show fluorescence emissions and their sensitivities 
decrease in the same order as written in the parentheses. These amino acids absorb 
energy between 230 and 290 nm and correspondingly emit light between 300 and 350 nm 
and hence can be used as intrinsic probes for studying induced structural changes in 
protein. As fluorescence emissions are strongly influenced by the neighboring residues 
and the local environment of the emitting residue, this technique is used as a direct 
measurement for studying the tertiary conformations of proteins. Briefly, if there is any 
conformational change occurring near the above mentioned aromatic amino acids, there 
will be a clear shift in the emission spectrum of the protein as the change in conformation 
in turn will alter the extent of the exposure of that intrinsic amino acid probe. If in case a 
protein lacks any of those amino acids they can be coupled to an external fluorophore 
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(usually an organic compound) for these studies. Being the most sensitive amino acid, 
Tryptophan dominates the weakly sensitive amino acids at specific wavelengths and 
hence its presence is most welcome for these studies. 
 As antimicrobial peptides tend to bind membrane mimicking agents like 
lipidosomes or micelles, the extent of binding can be quantitatively analyzed. Titration of 
known concentrations of any mimicking agents into a solution of peptide can be 
monitored with changes in emission spectra. The red shift or the blue shift upon binding 
is a general indication of the interaction and the extent of exposure of the fluorophore can 
be determined by binding of the fluorophore with fluorescence quenchers like acrylamide 
or iodine. 
1.5.2.3 Isothermal Titration Calorimetric binding studies 
 Isothermal titration calorimetry (ITC) is a well established technique for 
determining the thermodynamic parameters of interactions between two different 
molecules. It is a quantitative technique which involves the titration of one sample 
(ligand; L) into the other (macromolecular substrate; M) at a constant temperature and 
measurement of the exact heat change occurring as a result of binding for every injection. 
The thermodynamic parameters like ∆Hº, ∆Gº, ∆Sº and binding constants Ka or Kd along 
with the stoichiometric ratio or number of binding sites (n) can be obtained from 
analyzing the ITC data. The thermogram obtained from ITC depends on the choice of 
proper concentration ratios between the ligand [L] and the macromolecule [M], as well as 
the injection volume. Hence it is important to optimize the proper conditions before 
running the actual experiment.  
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 In an ITC experiment, the raw data for the amount of heat generated for every 
injection is given by the equation; 
qinj = ∆H x [L] x vinj         (a) 
The obtained raw data is corrected with the instrument blank and the dilution factor using 
the following equation; 
Qcorr = Qmeas – Q dil, ligand + Q instrument blank                     (b) 
The heat is measured as relative to the reference state that is defined totally as the excess 
enthalpy per mole of macromolecule,  < ∆H >, the total concentration of bound and 
unbound state of the macromolecule, and the volume. Thus the heat for ith injection is 
given as; 
Qi = < ∆H >i [M]tot,i Vcell - < ∆H >i-1 [M]tot,i-1 (Vcell – Vinj)  (c) 
For the case of one to one binding  
< ∆H > = (K[L] /1 + K[L])              (d) 
Where, ∆H is the change in enthalpy when one mole of the ligand binds to one 
macromolecule. When we take into account of the dilution factor and the amount of 
macromolecule getting ejected from the cell for every injection of ligand to keep the total 
volume a constant we end up with an equation which determining the actual ligand 
concentration as; 
[L] = - [ 1+ K([M]tot –[L]tot) ] + Ö ([ 1+ K([M]tot –[L]tot) ]2 + 4K [L]tot) / 2K (e) 
Further substitution of this equation in (d) and the resultant equation in (c), the values of 
K, ∆H and q can be determined. In addition to these the best value of stoichiometry of the 




1.5.2.4 NMR techniques- For the determination of solution structures and dynamics 
 Once an antimicrobial peptide is found to be active and its binding specificities 
are determined, the next step would be the determination of the three dimensional 
structure in its free and specific model membrane bound forms. The insights of these 
three dimensional structures can help one to address the details regarding the relationship 
between structure and activity. Nuclear magnetic resonance (NMR) spectroscopy is one 
of the powerful techniques that can be used for determining the structure and dynamics of 
small or macromolecules in solution. This technique provides direct information on the 
behavior of atomic nuclei spins that are sensitive to its surroundings. The following 
sessions will describe briefly the fundamentals and usage of NMR. 
1.5.2.4.1 NMR phenomenon 
1.5.2.4.2 Basic NMR parameters 
 The basic parameters are chemical shift, J coupling and relaxation. A brief 
description these important parameters are given in the following paragraphs.  
1.5.2.4.3 Chemical shift 
 The resonance frequency n for a given nucleus depends on its surrounding local 
electron distribution. As the electronic environment of the nucleus is affected by 
neighboring atoms, this effect is denoted as chemical shift, d. This is the parameter which 
allows detection and differentiation of signals for different protons in a molecule from 
simple chemicals to proteins. For the sake of convenience, the chemical shift value is 
given relative to some standards whose chemical shift data are set arbitrarily as zero. The 
universal standards are Tetramethylsilane (TMS) for chemical compounds and 2,2-
dimethyl-2-silapentanesulfonic acid for proteins samples. 
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d = 106(n - nref) / nref 
Where n and nref are the precession frequencies of the proton under analysis and TMS 
respectively (explain what are n and nref) as in the above equation. The frequency 
difference is divided by the reference frequency and hence chemical shift becomes only 
an intrinsic spin property and independent of the magnetic field applied. 
 The environmental influence on chemical shift values helps one to predict the 
conformation of a protein through the chemical shift values. The deviation of d values for 
spins in a given protein from those for the same spins in a randomly coiled protein is used 
to determine the secondary structure of the protein even before solving its 3D structure.  
1.5.2.4.4 Scalar or J coupling 
 Scalar coupling or J-coupling is caused by the interaction between two nuclei 
through the electrons in the intervening covalent bonds. J coupling alters the number of 
the spin energy states causing signal splittings. As the coupling interaction deceases 
dramatically with the increase of the interconnecting bonds, the connectivity information 
between two spins can be obtained through the values of J couplings. Coupling constant 
also depends on the dihedral angle between two adjacent X-H bonds described as by the 
Karplus equation (Karplus et al., 1976). J-couplings can provide various useful 
information regarding the secondary structure and dynamics. It is relied in the correlation 
experiments to identify spin-systems in which all the spins are coupled to one another.  
1.5.2.4.5 Relaxation 
 Relaxation describes how fast a nuclear spin returns to its equilibrium state when 
it is disturbed away from the equilibrium state. As the relaxation is influenced by the size, 
conformation and environment of a molecule, analyzing relaxation parameters can give 
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information regarding the geometry and dynamics of the molecule. Longitudinal or spin 
lattice relaxation time (T1) and transverse or spin-spin relaxation time (T2) are the two 
commonly used relaxation parameters.  
1.5.2.4.6 Nuclear Overhauser Effect (NOE) 
 Nuclear Overhauser effect occurs due to a transfer of energy occurring between 
two dipolar coupled nuclei when they are relaxing in space. As the intensity of NOE 
depends on the exact distance between two nuclei (NOE a 1/r6; where r is the distance 
between the two nuclei), it can be used to estimate the inter-atomic distances and finally 
lead to the structure determination of a molecule. In general the NOEs can be detected 
when the separation between two nuclei is within 5 Å. The flexible regions of any protein 
can also be analyzed through the heteronuclear NOE transfer rates as it is influenced by 
the local dynamics. The steady-state heteronuclear NOEs can be calculated from the ratio 
of peak intensities between spectra recorded with and without proton saturations.  
1.5.2.4.7 The advantages and limitations of solution NMR for structural studies 
NMR is an excellent tool to study the atomic-level resolution structure and 
dynamics of molecules in solution and has advantages and limitations over other 
available spectroscopic techniques. The major advantage is that protein can be 
investigated in a physiological buffer solution and crystal is not needed for structure 
determination. Many processes like unfolding/refolding, conformational changes, 
dynamics, ligand binding, and protein/protein interactions can be detected using NMR. 
The problem in crystallization such as the effects of crystal packing is not in NMR as the 
sample is prepared in solution. However, there are some limitations in NMR, e.g., 
proteins larger than 35 kDa are difficult to study using NMR due to their slow tumbling 
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rate. Higher temperatures like 25 to 35° C are more suitable for NMR studies but some 
recombinant proteins might not be stable at this high temperature. Again, as the time 
required for a complete NMR data acquisition varies from a few days to a couple of 
weeks maintaining the protein in its initial conformation might be a bit complicated. 
Hence if a protein is quite stable in solution for about seven days at the optimized 
experimental temperature, studying the structure and dynamics using NMR would be 
easier. 
1.5.2.4.8 General strategy of NMR structure determination 
 The general strategy of protein structure determination involves various stages 
like sample preparation, NMR spectrum acquisition, resonance assignments, restraint 
collection, structure calculation followed by refinement and structure evaluation. All 
these are common for any types of proteins but they have slight differences depending on 
size of the protein. The following sessions will give a glimpse of all these strategies.  
1.5.2.4.9 Sample preparation 
 The proteins expressed using recombinant techniques are generally enriched with 
two NMR active nuclei 15N and 13C, for the purpose of resonance assignments. The 
protein purification procedures are optimized in order to obtain a sample with a final 
concentration of 0.1 mM to 2.0 mM and a volume of 300 to 500 µL.  The choice or 
optimization of buffer conditions is very crucial for protein samples as there are many 
factors like pH, salt and the buffer’s chemical nature to consider. The first choice for 
optimization of buffer would be to increase the stability and solubility of the protein 
without any possible aggregation or precipitation for at least several days at a suitable 
temperature. The choice of buffers without non-exchangeable protons, with low ionic 
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strength and no metal contamination are also important to avoid the interference in the 
spectra. An addition of 5 to 10 % of D2O is always required in the sample solution for 
deuterium lock to maintain a constant magnetic field. 
1.5.2.4.10 Acquisition of NMR spectra  
NMR spectra recorded for protein samples are mainly focused on the 
determination of the chemical shift values for all distinguishable nuclei and their spatial 
connectivities. The basic experiments needed to get all these data depends on the size of a 
protein. For instance, in case of peptides recording the total correlation spectroscopy 
(TOCSY) can give chemical shift data for all the available protons, and the recorded 
nuclear Overhauser effect spectroscopy (NOESY) can detail the spatial interactions 
among protons where no heteroatom labeling is required. The dimensionalities of these 
experiments are increased for larger proteins to differentiate overlapping signals. In this 
case, isotope labeling is required. For instance, 3D 1H -15N-edited HSQC-NOESY and 
15N-edited HSQC-TOCSY can be used for structure determination of large peptides or 
small proteins.  
1.5.2.4.11 Resonance assignments  
 Assigning all the relevant peaks in a NMR spectrum could be the most time 
consuming process during protein structure determination. Solving a complete 3D 
structure of a protein involves different steps, where the primary step is sequence-specific 
backbone assignment. TOCSY and NOESY experiments like 15N-edited HSQC-TOCSY 
and 15N-edited HSQC-NOESY are used for small proteins and peptides. HNCACB and 
CBCACONH together with TOCSY-based experiments are used for medium-sized 
proteins. For large proteins, 4D NOESY, 3D HNCA, HNCOCA and 3D HCC-TOCSY 
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can be used for 13C, 15N-labeled samples.  As the standard chemical shift values are 
available for all the twenty amino acids in a random coil structure, calculating the 
deviations of the experimental chemical shifts with the literature data can give secondary 
structure prediction of a protein or peptide. 
1.5.2.4.12 Restraint collection 
After getting a list of all chemical shift values, different types of NOESY spectra 
are used in order to relate their spatial connectivities. The intensities or the volumes of 
the assigned peaks are later utilized for the structure calculations.  Angular restraints (f 
and Y) can be predicted from the chemical shift values of specific atoms like Ca, Cb and 
Ha using the TALOS program package. The number of distance restraints and angular 
restraints used for the structure determination are very crucial. For structure 
determination the distance restrains are generally classified as intraresidue, (i, i); 
sequential, (i, i+1); medium, (i, i+j), j < 5 and long range, (i, i+j), j > 5 NOEs. Other 
restraints like hydrogen bonding restraints are also utilized for refining the structures, 
experiments like H/D exchange and chemical shift temperature coefficients (DdNH/DT) 
can give details on amides involved in hydrogen bonding. 
1.5.2.4.13 Structure calculation and refinement 
The protein structure is calculated using all the experimental restraints on the 
amino acid sequence template. The conversion of the distance and torsion angle restraints 
into three dimensional structures can be done using different computer programs like 
CYANA, CNS or XPLOR-NIH. In general, the program performs gradient energy 
minimization in the torsion angle space for determining the three-dimensional structure 
that can fulfill the conformational restraints. Especially CYANA uses simulated 
34 
 
annealing combined with molecular dynamics in torsion angle space (dynamics) and 
utilizes a fast recursive algorithm to integrate the equations of motions. This calculation 
is restricted by all the experimental restraints and hence the quality of the calculated 
structure directly depends on the quality and number of the restraints given as input. All 
the calculated structures are tested for their convergence, where insufficient or incorrect 
experimental restraints get reflected in the poor convergence. For the structure refinement 
the problematic restraints are further checked and modified to obtain unambiguous high 
quality structures with very low conformational energy and high coordinate precision. 
Ramachandran plot and PROCHEK software can be used for the detailed analysis of the 
calculated structures. The convergence of all the calculated structures is given as Root 
Mean Square Deviations (RMSD) from the mean structure.  
1.6 Our investigations to address unresolved problems with HBD-3 
 Despite the fact that a lot is known about the antimicrobial peptides regarding 
their expression, evolution, structure, activity and other functional properties, there are 
still some queries about their mechanism. In particular, even though the biological 
activities of HBD-3 are well established, it is unclear how the secondary structure, high 
positive charge, hydrophobicity and tertiary structure are affecting its in vivo activity. As 
all the available AMPs do not have high sequence similarities, it is expected that their 
activities are dependent on their secondary and tertiary structures. But this is not sufficed 
to explain why HBD-3 has a broader spectrum of activity than HBD-1 or HBD-2 despite 
having a very similar tertiary structure. Also the correlation of HBD-3’s behavior with its 
unusually high positive charge may not explain why it shows salt resistant activity as 
electrostatic interactions are considered to be essential for the antimicrobial activity. Thus, 
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the peptide HBD-3 has many hidden elements that are required for performing its unusual 
behavior.  
 Our main focus lies in exploring the antimicrobial mechanism of HBD-3. We 
have tried to achieve this by performing several biophysical studies involving outer 
membrane mimicking agents to determine the behavior of this peptide under different 
environments. We have prepared lipid vesicles, detergent micelles and 
lippopolysaccharide (LPS) aggregates to study the conformation of the peptide when in 
complex. As the tertiary fold of the peptide was considered to be most important for its 
activity and specificity, the formation and localization of hydrophobic patches should 
have a large influence on the activity of HBD-3. So, we have designed several mutants in 
which all the cystine residues were mutated to other residues that created only slight 
changes in the overall charge and hydrophobicity. Initially, we wanted to identify the 
models in which the mutant peptide binds at different extents, hence POPG and POPC 
vesicles mimicking the Gram-positive cell membrane and mammalian cell membranes, 
respectively, were used. As we have determined that the peptide binds to POPG but not 
to POPC, we wanted to determine the solution structure of SDS bound structure and 
dynamics of the peptide to find out the region that shows better binding. On the other 
hand, as we know that the mutant is active against Gram-negative bacteria and the most 
expected site of interaction for this peptide is the LPS moiety of the cells, we attempted 
to solve the structure of the LPS bound structure of the peptide and study it’s binding 
with LPS. 
 Thus the project was believed to explain the influence or involvement of the three 
dimensional structure of HBD-3 in its biological activity by studying the properties of a 
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HBD-3 mutant (Def-A), and by comparing it with the available data on the wild type 
peptide from literature.  
 This thesis is organized such that the first chapter gives the general introduction 
about antimicrobial study and the importance of our project. The second chapter deals 
with all the methodologies in this study along with the materials used. Both the third and 
forth chapters discuss the results and discussions, where the third chapter discusses about 
the structure and dynamics of the mutant Def-A in SDS micelles and its activity against 
several Gram-positive and Gram-negative strains and the fourth chapter deals with the 
lipid specific binding properties of Def-A, where the Tr-NOE derived structure of LPS 
bound Def-A along with its binding affinity are discussed. 
 The fifth chapter summarizes the project and gives some possible future 
























CHAPTER 2: Materials and Methods 
 This chapter explains the methods in detail which are followed throughout the 
study and also gives the sources from which the materials were obtained to carry out all 
the experiments. The general materials are discussed in the first session followed by the 
specific experimental set up and details. The flow of this chapter is similar to the way the 
work was performed.  
2.1 Design and molecular cloning 
The amino acid sequences (Figure 3.1A) of reduced HBD-3 (rHBD-3) and its 
designed mutant analogue, Def-A, were back-translated to obtain their DNA sequences. 
The DNA template was synthesized by the polymerase chain reaction (PCR) using two 
complimentary long synthetic primer (Sigma-Proligo) strands of 88 and 98 bases (Figure 
2.1). For Def-A, the forward primer is an 88-mer (5¢-
GATCATGGCACATATGGGTATTATTAATACTCTGCAGAAATATTATGCGCGTG
TGCGTGGTGGTCGTTACGCGGTGCTGAGCGTGCTG-3¢) containing the start codon 
(ATG) together with the NdeI cutting site in the 5¢ region just before the peptide 




3¢)  has a stop codon before the XhoI cutting site in the 5’ region and a 21 bp overlapping 
region at its 3’ end. Similar forward and reverse primers were also designed for the 
rHBD-3 peptide with codons to generate all six Cys residues at their original positions. 
The codons were all optimized for over expression in the E. coli BL21 (DE3) strain. The 
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polymerase chain reaction (PCR) was used to construct the synthetic gene described in 
the next session. The PCR product was cloned into a pET-32a-derived vector (devoid of 
the thioredoxin tag and the S tag) which was digested previously with the same restriction 
enzymes (NdeI and XhoI). The fidelity of the ligation product was confirmed by 
sequencing before introducing into E. coli BL21 (DE3) strain for expression. 
2.1.1 Protocol followed for the molecular cloning 
Polymerase chain reaction was carried out for the formation of DNA template and 
their multiples using the two long primers as seeds. The table 2.1 lists the amounts of 





















Table 2.1:  Reagents and volumes used for the PCR 
Forward primer 0.5 µL  
Reverse Primer 0.5 µL  
10mM dNTP 2 µL  
MgCl2 6 µL  
10 X Buffer 10 µL  
Tag DNA Polymerase  0.4 µL   
H2O 81 µL  







Table 2.2: Temperature cycles and time intervals used for each cycle 
One Cycle  94° C 30 s 
Twenty five cycles  94° C 30 s 
 60° C 30 s 
 72° C 12 s 




                                
Figure 2.1: The primers used to construct the DNA templates for Def-A (above) and 




Figure 2.2: pET 32a derived vector. (A) Vector diagram of pET 32a. (B) 




The templates obtained from PCRs were purified by loading them on a 2% agrose 
gel and running at 80 Volt for 45 min and by further extraction using the QIAGEN gel 
extraction kit. Enzyme digestions for the purified templates and pET32a derived vectors 
were carried out by mixing the amounts given in table 2.3 and incubating for 2 hours at 
37 °C. 
 
Table 2.3: Volumes of different DNA substrates and enzymes used for double     
                  Digestion 
 Peptide’s template Vector 
DNA  50 µL 20 µL 
Nde1  3 µL 1 µL 
Xho1 3 µL 1 µL 
10 X Buffer 3 10 µL 3 µL 
H2O 34 µL 5 µL 
Total volume 100 µL 30 µL 
 
The QIAGEN gel extraction kit was used again to extract the enzyme digestion 
mixtures and both the extractions were subjected for ligation using T4 DNA ligase by 
adding them in proportions as shown in Table 2.4. 
 
Table 2.4: The volumes of DNA templates and enzyme used to ligate them 
Ingredients Volume  
Ligation Product (Peptide) 5.7 µL  
Ligation Product (Vector) 12.0 µL  
T4 DNA Ligase 0.3 µL  
10 X Ligase Buffer  2.0 µL  
 
 The ligation product was transformed into DH5α cells and plated on LB agar 
plates. The correct ligation product was confirmed by sequencing (used the standard 
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sequencing protocol) before introducing into the E. coli BL21 (DE3) strain for expression 
of peptides. 
2.2 Expression and purification of Def-A and rHBD-3 in LB and M9 media 
2.2.1 Media (LB and M9) used for the expressions 
 LB medium was prepared as per the directions of the manufacturer. While the 
minimal media (M9) used for15N labeling of samples was prepared by mixing all the 
ingredients given below: NH4Cl (1 g), Glucose (4 g), CaCl2 (0.01 g), MgSO4 (0.24 g), 
Na2HPO4 (6.78 g), KH2PO4 (3 g), NaCl (0.5 g), minimal vitamin stock solution (10 mg 
thiamine), 100 mg ampicillin and finally topping up to one liter using distilled deionized 
water. Both the media were autoclaved at 121 °C for 20 min before using, while reagents 
like 15NH4Cl, Glucose, CaCl2 and MgSO4 were prepared in distilled de-ionized water and 
added separately to the M9 medium upon sterile filtration.  
2.2.2 Expression of peptides in M9 media  
 A fresh clone of E. coli, harboring the vector with the insert was grown in 5 mL 
of Luria Bertani (LB) medium (containing 100 µg/mL of ampicillin) overnight at 37 °C 
and then diluted into 1L of M9 minimal medium with 1g 15NH4Cl to continue culturing at 
the same temperature until the mid-log phase (OD600 = 0.6). The cells were then induced 
using 0.2 mM IPTG (isopropyl-b-d-thiogalactopyranoside) for 14 h at 16 °C before 
harvesting. Harvested cells were lysed using ultrasonication in 10 mM phosphate buffer 
at pH 6.2 and majority of the peptide was found in inclusion body. 
2.2.3 Purification of peptides 
The peptide from the cell debris was extracted using 60% acetic acid and loaded 
directly into HPLC with a RP-C18 column for purification. Water with 0.1% TFA was 
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used as the running buffer ‘A’ and acetonitrile with 0.1% TFA was used as buffer ‘B’ for 
eluting the protein. Both the desired peptides were eluted at around 36 % of eluent B. The 
peptide checked using 16.5 % tricine PAGE for purity and their molecular weights were 
confirmed by ESI-MS. 
2.3 Tris-Tricine Protein/Peptide Separation Gels 
 As SDS PAGE may not be suitable for running or viewing small peptides a 16.5% 
Tris-Tricine PAGE was used for analyzing the expression and purity of peptides. The 
recipe used for making gels of dimension (1mm x 8 cm x 10 cm) is as in table 2.5: 
Table 2.5: Composition of separating and stacking gels 
 Separating Gel Stacking Gel 
40% Acrylamide 5.48 mL 410 µL 
Tris-HCl/SDS pH 8.45 4.44 mL - 
4× Tris-HCl pH 6.8 - 1.04 mL 
Glycerol 87% 2.11 mL - 
H2O 1.23 mL 2.67 mL 
10% SDS - 40 µL 
10% APS 20 µL 10 µL 
TEMED 10µL 5µL 
 
Shown below are the Formulae used for preparing the stock solutions necessary for the 
tris/tricine gels; 
Tris-HCl pH 8.45 
Tris-base 182 g 
10% SDS 15 mL 
Adjust to pH 8.45 with HCl 
H2O to 500 ml. Store at 4 °C up to 1 month 
 
4× Tris-HCl pH 6.8 
Tris-base 6.05 g  
Adjust pH to 6.8 with 
HCl 
 






2× Tricine Sample Buffer 
4× Tris-HCl pH 6.8 2 mL 
Glycerol 87% 2.4mL 
DTT 0.31g/ 2mL of 1M DTT 
10% SDS 2.5 mL 
Coomassie Blue G-250 2 mg 
H2O to 10 ml  
 
Anode Buffer (+)  
Tris-base 24.22 g 
Adjust pH to 8.9 with 
HCl 
 
H2O to 1000 mL  
 
Cathode Buffer (-) 
Tris-base 12.11 g 
Tricine 17.92 g 
10% SDS 10 mL 
Do not adjust pH  
H2O to 1000 ml  
 
2.4 Bactericidal assays 
2.4.1 Hancock’s colony count assay 
 Different strain cultures were inoculated overnight in full strength MHB medium 
until it reached a colony forming unit (CFU) of approximately 1 x 108 per mL. The 
overnight culture was diluted using either quarter or full strength of MHB to a final CFU 
of 1 x 105 (Ten times serial dilutions were made in seven tubes and 25 µL of each was 
dropped on MHA plates to confirm the CFU mL-1). 50 µL aliquots of culture at the above 
concentration was mixed with 50 µL of peptide at six different concentrations (peptides 
were prepared in ¼ or full strength of MHB medium as shown below) in micro tubes and 
incubated at 37 °C overnight at 220 rpm. One positive control (sans both peptide and 
strain) and one negative control (sans only peptide) were also used to justify the result. 
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After the incubation, 10 µL from each tube was taken and serially diluted in ratios of 1 
to10 using saline into seven tubes. 25 µL from each diluted tube was dropped onto the 
MHA plates and further incubated overnight in order to count the colonies.  
The CFU per milliliter for each bacterial strain was calculated as shown: Bacillus 
megaterium: (25+30)/2 * 40 * 106 = 1100 *106 = 1.1 * 109 (CFU/ mL) which was further 
diluted to 1.1 *106 (CFU/ mL) for the assay, where 25 and 30 depicts the number of 
colonies grown on the duplicated culture plates and 106 is the dilution factor and the 
value was multiplied by 40 as only 25 µL was plated for counting the colonies. 
2.4.2 Radial diffusion assay 
The activity of Def-A was also screened against Bacillus megaterium and other 
bacterial strains using Radial Diffusion Assay (Takemura et al., 1996). Briefly, bacteria 
were grown overnight (~16 h) at 37 °C in 5 mL of trypticase soy broth (TSB).  To obtain 
the mid-logarithmic phase growth (OD600 = 0.4), it was inoculated into 50 mL of fresh 
TSB and incubated for an additional 1 hr at 37 °C. The bacteria were centrifuged at 900 x 
g for 10 min at 4 °C, washed twice with cold 10 mM sodium phosphate buffer at pH 7.4 
and re-suspended in 10 mL of the same buffer. The re-suspended bacteria (~ 1 x 106 
CFU) was added to 10 mL of previously autoclaved, warm (40 °C) 10 mM sodium 
phosphate buffer containing 3 mg of powdered TSB medium, 1% (w/v) of low 
endosmosis-type agarose (Sigma) and a final concentration of 0.02% (v/v) Tween-20 
(Sigma). After dispersing, bacteria-containing agar was poured on a petri dish to form a 
uniform layer of ~2 mm thickness. A 3 mm diameter biopsy punch was used to make 
evenly spaced wells. After adding 5 µL of Def-A solution in a series of concentrations 
along with the positive and negative controls, the plate was incubated for 3 h at 37 °C. 
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Then a double strength (6 mg) TSB solution with 1 % (w/v) agarose was overlaid and 
further incubated at 37 °C for 6 h. Finally the diameter of the clear zone (surrounding the 
3 mm well) was measured using an Olympus SZ40 Zoom Stereo Microscope. The 
experiments were repeated twice to estimate the error. 
2.5 Interaction of Def-A with lipid vesicles, micelles and helix inducing solvents 
 The extent of change in conformations and the lipid mediated binding properties 
of Def-A was studied using several lipid vesicles like POPG, POPC and POPE and 
micelles like SDS and DPC. The alpha helical propensity of Def-A was tested using the 
helix inducing organic solvent TFE.  
2.5.1 Preparation of large unilamellar vesicles  
 Large unilamellar vesicles (LUV) of POPG, POPC and POPE (Avanti Polar 
Lipids, Alabaster, AL, USA) were prepared by the previously described extrusion method 
(Prenner et al., 1999; Jing et al., 2003). Briefly, the chloroform in the lipid mixture was 
evaporated to dryness using a stream of N2 gas and further subjecting into vacuum 
overnight. Dry lipid film was re-suspended in phosphate buffer (pH 7.4) and kept for 
several hours in order to hydrate them to form multilamellar vesicles. The lipid 
suspension was freeze-thawed several times using liquid N2 and hot water and then 
extruded twenty times through polycarbonate membranes with 100 nm diameter pores to 
generate homogeneous LUVs and their homogeneity was confirmed using Dynamic 






2.5.2 CD spectroscopy: strategy and acquisition  
 The secondary structural properties of Def-A in different conditions were 
recorded in a Jasco J810 spectropolarimeter (Jasco Corporation, Tokyo, Japan) at room 
temperature using 0.1 cm path length cuvette. In general, all samples were prepared in a 
10mM sodium phosphate buffer at pH 7.4.  The concentration of Def-A was maintained 
at 20 µM in all cases while the final concentrations of all lipid vesicles and micelles were 
maintained well above their critical micelle concentrations. The concentrations used 
were: SDS, 20 mM; POPG, 1 mM and POPC, 1 mM. TFE titrations were carried out by 
adding appropriate amounts of TFE buffer mixture into the peptide stock solution to 
obtain the desired solution conditions. The TFE concentration was increased in a step 
wise manner from 10% till 90%. The mean residue molar ellipticity [q] in deg.cm2.dmol-1 
was calculated for all the sepctra using the following equation: 
                          
Where q is the ellipticity recorded in millidegrees, c is the protein concentration in 
mg/mL, L is the path length in cm, Mr is the protein molecular weight and NA is the 
number of amino acids in the protein. The percentages of α-helix, β-sheet and random 
coil were calculated from the CD spectra using the method described at www.embl-
heidelberg.de/~andrade/k2d/. 
2.5.3 Isothermal Titration Calorimetry 
 ITC experiments were performed at 25 ºC on a Microcal VP-ITC machine. The 
binding of Def-A with POPG vesicles was carried out by titrating 0.5 mM POPG LUVs 
[q] =   C x L x NA 
q x 100 x Mr 
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against 50 µM Def-A loaded in the cell. The binding of Def-A with LPS aggregates was 
carried out by loading LPS (10 µg/mL) in the cell and by titrating 1 mM of Def-A loaded 
in the syringe against the LPS aggregates. All samples were prepared using 10mM 
phosphate buffer at pH 7.4 and degassed under vacuum for 10 min prior to usage. In 
order to measure the heat change upon binding, the titrant was introduced into the cell 
through 30 injections of 10 µL aliquots at an interval of 4 min. The duration of each 
injection was set at 20 sec and the reaction cell was stirred continuously at 300 rev per 
min. The heat of dilution was adjusted by subtracting the heat produced during a control 
experiment in which either POPG LUVs or Def-A was titrated into the phosphate buffer 
containing no peptide or no LPS respectively. The thermodynamic parameters were 
obtained by fitting the ITC data using a single site binding model provided by the Origin 
5 package. Further ∆G and ∆S were calculated using the following relations ∆G = -RT ln 
Ka and ∆S = (∆H-∆G) / T, respectively. 
2.5.4 Fluorescence emission spectroscopy  
 The fluorescence experiment was carried out by titrating a known concentration 
of POPG or SDS solution into Def-A at 4 µM. All the samples were prepared in 10 mM 
phosphate buffer at pH 7.4. The tyrosine in the peptide sequence was excited at 270 nm 
and the emission was monitored at 303 nm. The titration was carried until the 
fluorescence value got saturated.  
2.5.5 NMR spectroscopy: Data acquisition, processing, assignment and structure 
determination 
 NMR spectra were recorded at two different temperatures (35 ºC for SDS bound 
Def-A and 15 ºC for LPS bound Def-A) on a Bruker Avance-500 MHz spectrometer 
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equipped with a cryoprobe. For NMR spectra of SDS bound Def-A, the sample was 
prepared in 500 µL H2O containing 0.5 mM peptide, 5% D2O and 50 mM SDS-d25 
micelles. The final pH of the solution was adjusted to 4.2 using diluted NaOH and HCl. 
For LPS binding studies, 500 µL of H2O containing 0.5 mM peptide at pH 4.2 was 
titrated with a known concentration of LPS aggregates. The concentration of LPS 
aggregates required to collect the tr-NOE data for the LPS bound Def-A was determined 
by titrating the Def-A NMR sample with 10 µL of 10 mg/mL LPS stock solution and 
recording several 1H-NMR spectra. The point of saturation was chosen when all the 
available peaks of protein (without any loss) became broad, and there is no precipitation 
in the sample. At this point 3D 15N-edted NOESY-HSQC at different mixing times was 
recorded to choose the one that generates most NOE peaks without significant spin 
diffusion. For both the samples 3D 15N-edted TOCSY-HSQC and 3D 15N-edted NOESY-
HSQC were recorded for resonance assignment and structure determination. 512 complex 
points were recorded at a spectral width (SW) of 8012 Hz for the direct observation 1H 
dimension and 128 complex points were recorded at a SW of 4502 Hz for the indirect 1H 
dimension. For 15N, totally 44 complex points were recorded at a SW of 1115 Hz. All 
experiments we recorded using a relaxation delay of 1s. The 15N time domain data were 
doubled by linear prediction. The data were zero-filled and Fourier transformed to obtain 
a final data set comprising of 1024, 128, 256 data points in direct 1H dimension and 
indirect 15N and 1H dimensions. The raw data were processed using NMRPipe (Delaglio 
et al., 1995) and resonance assignments were done using NMR package and Sparky 
(Goddard et al.,). Backbone and side-chain 1H and 15N spins were assigned from the two 
3D spectra. For SDS bound peptide all the NOEs were obtained from 2D and 3D NOESY 
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spectra recorded at mixing times of 80 and100 ms respectively whereas for LPS bound 
peptide the NOEs were obtained from the 3D NOESY spectrum recorded at 150 ms. 
2.5.6 Relaxation Study 
 The relaxation study was carried out for the SDS bound Def-A. 15N relaxation 
experiments were carried out using the same sample as the one used for structural studies. 
Relaxation times T1 and T1r and {1H}-15N heteronuclear NOE were measured using the 
inversely detected two-dimensional (2D) NMR experiments as described previously 
(Farrow et al., 1995; Mikael et al., 1996). Relaxation times T1 were measured by 
recording a series of 2D spectra at the following time delays: 10, 100, 200, 360, 440, 550 
and 650 ms. A recycle delay of 1 s and 8 scans were used. T1r values were measured 
using the relaxation delays: 5, 40, 60, 80, 100 and 130 ms at a spin-lock power of 1.6 
kHz, a recycle delay of 2.5 s and 8 scans. {1H}-15N NOE data were obtained from the 
signal intensities measured with and without 1H saturation. For proton saturation, a train 
of 120º 1H pulses were applied for a period of 3 s after a recycle delay of 3 s. Each 
spectrum with spectral widths of 912 Hz for 15N and 8012 Hz for 1H was recorded using 
100 and 512 complex points in t1 and t2 dimensions, respectively. 
2.5.7 Structure Calculation 
 The distance restraints were generated from 1H-1H NOE cross peak intensities 
obtained from the NOESY spectra after calibration. Initial structures were generated by 
backbone torsion angle restraints and distance geometry using CYANA-2.1 (Herrmann et 
al., 2002). A total of 200 structures were calculated and 10 lowest energy structures with 
no distance violations greater than 0.2 Å or dihedral angle violations larger than 2º were 
selected for further refinement using CYANA’s built-in simulated annealing protocol.  
53 
 
2.5.8 Relaxation Data Analysis. 
 Spin-spin relaxation time T2 was calculated using the following equation  
1/T1r=1/T1 sin2q + 1/T2cos2q        (1) 
where  q = atan (Dw/w1) in which Dw is the resonance offset and w1 is the spin-lock field 
strength. The relaxation data were analyzed using the following relations (Farrow et al., 
1995): 
1/T1 = d2/4[3J(wN) + J(wH - wN)  + 6J(wH + wN)] + c2J(wN)   (2) 
1/T2 = d2/8[4J(0) + 3J(wN) + J(wH - wN)  + 6J(wH ) + 6J(wH + wN)] + c2/6[4J(0) + 3J(wN)] 
          (3) 
NOE = 1 + T1(gH/gN)(d2/4)[6J(wH + wN) - J(wH - wN)]   (4) 
where d  = (µ0h/8p2) gHgNrNH-3, c=wN(s|| -s^ )/Ö3, g  is the gyromagnetic ratio, h is 
Planck’s constant, µ0 is the permeability of a vacuum, rNH is the N-H bond length (1.02 
Å), s|| ands^  are the parallel and perpendicular components of the assumed axial 
symmetric chemical shift tensor (s|| -s^ = 170 ppm). A single overall tumbling time is 
insufficient to describe the overall motion of a non-spherical or unfolded protein. To 
obtain physically meaningful order parameters for Def-A that is partially unfolded, we 
used our previously established method (Yang et al., 1997) to extract dynamics 
parameters on a per residue basis. In this case, the spectral density function J(w) is given 
by   
J(w) = 0.4[S2tloc/(1 + w2tloc2) + (1 - S2) te/(1 + w2te2)]   (5) 
where tloc is the apparent correlation time for a specific residue and te is the effective 
correlation time that satisfies the relation te << tloc.  
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2.5.9 Docking of Def-A with LPS  
 The Tr-NOE derived structure of Def-A was docked on to LPS by the program 
AutoDock (Morris et al., 1998) following the protocol published by Bhattacharjya et al., 
2007. The atomic coordinate of LPS (1QFG), was obtained from the co-crystal structure 
of LPS and Fhu A (Ferguson et al., 1998) submitted in the protein data bank. LPS was 
chosen as the macromolecule and Def-A was considered as the ligand. The grid map or 
affinity map representing the macromolecule was constructed using 70 x 80 x 80 points, 
with a grid spacing of 0.375 Å, centered at the H2 atom of the glucosamine II residue of 
the lipid-A moiety. During docking, only the side chains of residues from Val-20 to Thr-
35 (residues with least RMSD in the structure) were defined as flexible while the 
backbone and side chains from all the other residues were kept rigid. Thus the LPS/Def-
A complexes were generated from this starting point using a Lamarckian genetic 
algorithm (LGA) with a translation step of 0.2 Å, a quaternion step of 5 Å, and a torsion 
step (tstep) of 5 Å. The maximum number of energy evaluations increased to 15,000,000 
with the number of individuals in the population maintained as 500 and one hundred 
LGA docking runs were performed. Finally 100 possible binding conformations were 
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CHAPTER 3: Structure and Dynamics of Def-A Bound to SDS and its  
      Bactericidal Activity  
 
This chapter discusses the results obtained from the structural and dynamics 
studies of Def-A in the presence of SDS micelle and the comparison of Def-A’s 
bactericidal activity with the reduced form of the wild type peptide (rHBD-3). 
 Def-A was found to be active against several bacterial strains but the activity 
being influenced by the ionic strength of the environment. When subjected to vesicles 
like POPG or to micelles like SDS, Def-A changed from a random coil structure to an 
ordered helical form. The structure of Def-A in SDS micelle was determined which 
revealed that the peptide was folded into two distinct helices separated by a proline kink 
in the presence of micelles. From the structure, we propose that the long N-terminal helix 
with many hydrophobic residues should be inserted inside the micelle while the C-
terminal helix with one large positive charge patch should be located outside the micelle 
and interacts with the charged head groups of the micelle. The model is also supported by 
NMR relaxation and H/D exchange data. The obtained results indicated that apart from 
the distribution and number of positively charged residues and hydrophobic residues, the 
three dimensional structure of a peptide also plays an important role in the antimicrobial 
selectivity and salt dependent activity of human beta defensins.  
3.1 Design, expression and purification of Def-A and rHBD-3 
3.1.1 Rationale behind the design of mutant Def-A 
 As mentioned earlier the linear analogue of HBD-3 (Figure 3.1A) was designed 
mainly to study the importance of the 3D structure in its activity. All the cysteine residues 
were mutated with an intension to examine the influence of the peptide conformation on 
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the activity and binding to different membrane mimicking reagents. The linear peptide 
was designed so that there is a slight increase in the overall hydrophobicity and positive 
charge. The first Cys was mutated into Ala to facilitate the alpha helical formation in the 
N-terminal region similar to the short helix seen in the wild type. The second last Cys 
was changed to a basic residue for increasing the overall charge while others were chosen 
to slightly increase the hydrophobicity.  
3.1.2 Expression and purification of Def-A and rHBD-3 
 Along with the mutant Def-A, HBD-3 in its completely reduced form (rHBD-3) 
was also expressed in order to compare their activities against bacterial strains. The 
expression conditions were optimized such that both the peptides could be extracted 
directly from the inclusion body after ultra-sonication. During sonication most of the 
impurities were solubilized in the lysis buffer. The acetic acid extract was further purified 
with RP-HPLC using a waters C-18 column and pure peptides were obtained (Figures 
3.1B, 3.2A and 3.2B). Due to the slight increase in hydrophobicity, Def-A was eluted 
with one minute delay under identical conditions (Figures 3.2A and 3.2B). Overall this 
new method has reduced the number of purification steps and facilitated the purification 
procedure. A final yield of ~8 mg protein per liter of culture was obtained. The 
lyophilized sample had very high solubility in pure water because of its high dielectric 
constant. rHBD-3 was expressed in a completely reduced form under our experimental 
conditions and special care was taken to maintain its reduced form throughout the 
experiments. The lyophilized rHBD-3 was dissolved in water and treated with 100 mM 
DTT for 1 h to make sure that there is no S-S bonds present and the mixture was again 
purified by HPLC, the eluted rHBD-3 was lyophilized and purged with N2 gas to remove 
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the air contaminants and aliquoted into several tubes and stored at -80 °C. The reduced 






Figure 3.1: Sequence comparison of Def-A with HBD-3 and Tricine PAGE of Def-A 
and rHBD-3. (A) The primary amino acid sequence of both HBD-3 and Def-A were 
aligned to show the cysteine mutations. Disulfide pattern in HBD-3 is shown using 
straight lines and cysteine and mutated resides are underlined where rHBD-3 is devoid of 
any disulfide linkages (B) A 16.5% Tricine gel shows the expression level and purified 
bands of Def-A and rHBD-3; where lanes 1, 2 and 3 depict before induction, after 
induction and purified fractions of Def-A, respectively, lane 4 for the molecular marker, 
lanes 5, 6 and 7 show the results before induction, after induction and purified fractions 








Figure 3.2: Analytical HPLC profiles and ESI-MS determination. (A) and (B) Shows 
the elution profiles of Def-A and rHBD-3 when loaded into a Waters RP-C18 analytical 
column and eluted using acetonitrile gradient. Arrow heads indicate the peaks of Def-A 
and rHBD-3. (C) and (D) shows the ESI-ms analysis of unlabeled Def-A and rHBD-3 
respectively with a series of multiply charged ions corresponding to the homogeneous 
peptides. (E) and (F) shows the molecular mass of unlabeled Def-A as 5202.9 ± 0.6 and 
rHBD-3 as 5161.9 ± 0.6. 
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3.2 Activity against bacterial strains 
The activity of Def-A was initially screened using radial diffusion assay (Figure 
3.3) (Takemura et al., 1996) and found it to be active against Bacillus megaterium. Hence 
for the further determination of MIC values we used Hancock’s microdilution method to 
test the activity of Def-A and rHBD-3 on two Gram-positive (Bacillus megaterium and 
Staphylococcus aureus) and two Gram-negative (Escherichia coli and Pseudomonas 
aeuroginosa) strains. Both peptides when incubation overnight with specific initial 
inoculums of strains (Table 3.1) showed concentration dependent killing ability (Table 
3.2 for Def-A and 3.3 for rHBD-3). The MIC value, which is defined as the minimum 
concentration of the peptide required to inhibit the visible growth of bacteria, was 
determined using this method. The results were highly consistent for all the repeats. The 
Peptide concentration at which inhibition above 95% of the cell population is observed is 
considered to be the Minimum inhibitory concentration for that particular strain. Except 
for Bacillus megaterium (the activity against this strain is not available for the wild type 
HBD-3 in the literature), the wild type HBD-3 is especially active against this strain than 
all the other strains tested as also observed by others  (Harder et al., 2001, Hoover et al., 
2003, Wu et al., Shelburne et al., 2005, Starner  et al., 2005). Here, we found that both 
our peptides are active only at low ionic strength (quarter strength of MHB medium 
containing 0.13 mM Ca2+ and 0.10 mM Mg2+) (Table 3.6)  which is quite comparable 
with the results published by other groups (Kluver et al., 2005 and Hoover et al., 2003), 
while Def-A shows slightly higher activity than rHBD-3. This can be explained on the 
basis of the increased hydrophobicity and positive charge of Def-A due to mutation. At a 
higher ionic strength (full strength of MHB medium containing 0.5 mM Ca2+ and 0.4 mM 
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Mg2+) there is considerable decrease in activity (MIC ≥ 300 μg/mL for both the peptides) 
which is different from the wild type’s specific salt insensitive behavior (Harder et al., 
2001). Previously many researchers have clearly shown that the presence of cations in the 
medium will affect the electrostatic interaction of the mutant peptides with the negatively 
charged bacterial cell wall but either very high hydrophobicity or oligomerization might 
overcome this effect (Kluver et al., 2005). Hence we carried out the study of amphipathic 
structure in presence of membrane mimicking agents to explore further the reason behind 




Figure 3.3: Antibacterial activity of Def-A. (A) Radial diffusion assay. (B) Comparison 
of antibacterial activity of Def-A (■) with tetracycline (O) and ampicilin (∆). The error 
bars are smaller than the size of the symbols used here and thus are not plotted. The insert 







Results obtained from the Hancock’s Microdilution assay for Def-A and rHBD-3 
are listed below#: 
Table 3.1: Colony Forming Units per milliliter (CFU/mL) for each strain used 














Table 3.2: Results showing the presence (+) or absence (-) of bacterial visible 
growth when different strains were induced overnight with varying 
concentrations of Def-A 
Def-AConcentration 
(µg/ml) BM1 BM2 EC1 EC2 PA1 PA2 SA1 SA2 
Positive control + + + + + + + + 
Negative control - - - - - - - - 
100 - - - - - - - - 
50 - - - - - - - - 
25 - - - - - - - - 
12.5 - - - - - - - - 
6.25 - - + + + + + + 




Table 3.3: Results showing the presence (+) or absence (-) of bacterial visible 
growth when different strains were induced overnight with varying 
concentrations of rHBD-3 
rHBD-3 Concentration 
(µg/ml) BM1 BM2 EC1 EC2 PA1 PA2 SA1 SA2 
Positive control + + + + + + + + 
Negative control - - - - - - - - 
100 - - - - - - - - 
50 - - - - - - - - 
25 - - + + + + + + 
12.5 - - + + + + + + 
6.25 - - + + + + + + 








Table 3.4: Colony forming units per mL determined for bacterial strains 




BM1 BM2 EC1 EC2 PA1 PA2 SA1 SA2 
Positive control 3.4e9 3.1e9 4.4e9 5e9 1.0e9 1.0e9 2.8e9 1.2e9 
Negative control NC NC NC NC NC NC NC NC 
100 NC NC NC NC NC NC NC NC 
50 NC NC NC NC NC NC NC NC 
25 NC NC NC NC NC NC NC NC 
12.5 NC NC 1.4e5 2.5e5 2.8e6 5.5e6 3.7e7 4.0e6 
6.25 NC NC 1.6e9 2.3e9 6.0e9 4.3e9 8.9e8 9.4e8 
3.13 8.0e5 7.5e5 NC NC NC NC NC NC 
 
 
Table 3.5: Colony forming units per mL determined for bacterial strains 




BM1 BM2 EC1 EC2 PA1 PA2 SA1 SA2 
Positive control 3.6e9 4.4e9 1.e9 1.0e9 2.8e9 1.2e9 4.8e9 1.2e9 
Negative control NC NC NC NC NC NC NC NC 
100 NC NC NC NC NC NC NC NC 
50 NC NC NC NC NC NC NC NC 
25 NC NC 3.2e5 1.8e5 3.0e6 3.9e6 4.1e7 2.7e6 
12.5 NC NC 3.4e9 2.2e9 1.8e9 2.5e9 4.7e9 3.1e9 
6.25 NC NC NC NC NC NC NC NC 
3.13 9.1e5 6.9e5 NC NC NC NC NC NC 
 
#Abbreviations used in all the tables; BM (Bacillus megateium), EC (Escherichia coli), 
PA (Pseudomonas auroginosa) and SA (Staphylococcus aureus) and the numbers 1 and 2 






   
 
 
Table 3.6: Minimum Inhibitory Concentration* (MIC in µg/mL) for Def-A and 







aureus       
ATCC 25923 
Escherichia 





Def-A 3.13 (>300) 12.5 (>300) 12.5 (>300) 12.5 (>300) 
rHBD-3 3.13 (>300) 25.0 (>300) 25.0 (>300) 25.0 (>300) 
HBD-3& NA# 3.13 (150) 6.0 (>300) 13.0 (37.5) 
* MIC values at  quarter strength of MHB  are given as italicized numbers 
while MIC values at full strength MHB are given in parenthesis,  
&MIC values for the native HBD-3 were adapted from Kluver et al., 2005 for 
comparison  












3.3 Conformational changes upon binding to model membranes. 
 Def-A changed its secondary structure from a random coil form to α-helix 
structure when subjected to any membrane mimicking medium as seen from the CD 
spectra (Figure 3.4). Even though this is a general phenomenon for most antimicrobial 
peptides, Def-A shows some of the following peculiar features. The secondary structure 
of Def-A in POPG vesicles is different from that in SDS (Figure 3.4) indicating that even 
though both models share the similar charge at the head group the conformation is 
different due to the size, length and arrangement of the molecules forming the micelle or 
vesicle. This explains the influence of the environment on the peptide conformation.  
 The titration of Def-A using SDS micelles shows that the transition in the 
conformation occurs at a concentration higher than its CMC (change occurred at 6 mM of 
SDS in phosphate buffer) value. It was found that the structural transition occurred during 
the titration is not smooth (Figure 3.5) as the peptide showed precipitation at lower 
concentrations of SDS (< 6 mM). This shows that Def-A interacts with SDS even before 












Figure 3.4: Circular Dichroism spectra of Def-A under different conditions. The far-
UV CD spectra of 20 µM Def-A recorded in 10 mM phosphate buffer (····), 20 mM 




Figure 3.5: Circular Dichroism spectra of Def-A upon titrating with SDS solution. 
The far-UV CD spectra of 20 µM Def-A recorded in 10 mM phosphate buffer upon 
increasing concentration of SDS concentration where the peptide shows aggregation 
when SDS concentration is below its CMC but the same peptide goes back into solution 
with a helical fold above the CMC value. 
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3.4 Isothermal Titration Calorimetry shows the binding of Def-A with POPG 
vesicles 
 Both SDS and POPG molecules share similar charged head groups and aliphatic 
tail regions, and their arrangements in the form of micelles (SDS) or vesicles (POPG) 
makes them suitable to mimic bacterial membranes. The strong affinity towards POPG or 
SDS is an indirect indication of the efficiency/potency of an AMP. The enthalpy change 
upon Def-A binding to the negatively charged POPG vesicles was hence investigated by 
isothermal calorimetric experiment. The heat change upon addition of POPG was 
saturated after 15 injections (around 60 min) indicating the completion of the binding 
process. Figure 3.6A shows the binding thermogram and Figure 3.6B shows the 
dependence of the net heat of the binding on POPG:Def-A molar ratio. The ITC titration 
profile clearly shows that the binding between Def-A and POPG is exothermic. The 
thermodynamic parameters (Table 3.7) determined from the experiment indicate that the 
binding is thermodynamically favored with nanomolar affinity. Solving the structure of 
Def-A bound to POPG vesicles would be comparatively more suitable than Def-A bound 









Figure 3.6: Isothermal calorimetric titrations for the binding of Def-A to POPG 
vesicles. (A) Injection of 10 µL aliquots containing 0.5 mM POPG vesicles into a 
solution of 50 µM Def-A in 10 mM phosphate buffer at pH 7.4 resulting in the spikes, 
reflecting the heat change upon each addition. (B) Plots of the heat change as a function 
of POPG:Def-A molar ratio. 
Table 3.7: Thermodynamic parameters of Def-A interaction with POPG 
vesicles 
Ka (106 M-1)   17.54 ± 3.86 
∆H (kcal mol-1)    -8.564 ± 0.072 
∆S (cal K-1 mol-1)    4.435 
∆G (kcal mol-1)   -9.871 




3.5 NMR Studies of Def-A in SDS Bound State. 
 The 1D 1H spectrum of Def-A in the absence of SDS shows that Def-A adopts a 
random coil structure in water, while the 1D 1H spectrum in the presence of 50 mM SDS 
indicates that Def-A forms certain structures in micelle, consistent with the CD data 
(Figure 3.7A and B). Figures 3.8A and B shows the 2D 15N-1H HSQC spectra with 
assignments for Def-A in the absence and presence of SDS. All peaks in the presence of 
SDS are broader than those in the absence of SDS due to the binding of Def-A to SDS 
micelles. We observed very few NOEs in aqueous solution which were insufficient to 
define the structure of the free Def-A. Hence we solved only the structure for the SDS 
bound form. Resonance assignments were made according to the methods published 
previously (Marion et al., 1989; Wuthrich et al., 1986). We have assigned ~90% NOE 
peaks in the 3D 15N-edited NOESY-HSQC spectrum, and obtained 496 unambiguous 
NOEs.  
 The relative NOE intensities and connectivities are shown in Figure 3.10A. The 
characteristic dαN(i,i+4) NOEs, which can generally be observed for α-helices, were 
present in the segments of I2-Y18 and Q29-T35 although chemical shift index (derived 
from Ha only) shows the entire peptide has high propensity to form helical structures 
except for several residues (Figure 3.9). The absence of dαN(i,i+4) and dNN(i,i+2) NOEs in 
the C-terminal region (Figure 3.10A) indicates that this region might have less defined  
helical structure. A total of 496 NOE restraints (174 intra-residue, 228 sequential and 94 
medium range) and 52 dihedral angle restraints derived from chemical shifts with 
TALOS (Cornilescu et al., 1999) were used for structure calculation. The refined 
structure of Def-A shows two helices (one long and the other short) separated by a 
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proline residue at the 25th position (which introduces a kink between them) and no 
interactions between the two helices are observed (Figure 3.10B). The N-terminal long 
helix is composed of more hydrophobic residues than the C-terminal helix. The presence 
of a few charged residues in the first long helix reduces its interaction with the 
hydrophobic core of the SDS micelles. 
 
Figure 3.7: 1D 1H Spectra of 0.5 mM Def-A. In the absence of SDS at 15 °C (A) and in 




Figure 3.8: 1H-15N heteronuclear single quantum correlation spectra of 0.5 mM Def-











Figure 3.9: Chemical Shift Index. Ha chemical shift deviations from the random coil 












Table 3.8: NMR and Structure statistics for SDS bound 
peptide 
Total NOE restraints   496 
Intra-residue              174 
Sequential (ïi-jï= 1)     228 
Medium range (1< ïi-jï < 5)     94 
Long range        0 
Dihedral angle restraints   52 
Hydrogen bond restraints      0 
Structure statistics  
No. of distance violations of > 0.20 Å    2 
No. of dihedral angle violations of > 5°   0 
Max. dihedral angle violation (°)  3.89    
Max. distance constraint violation (Å)  0.37 
Average RMS deviations (Å)  
Backbone atoms (Full length)    2.420 
Backbone atoms (residues 1-27)    0.393 












Figure 3.10: NOE intensities and connectivities and the solution structure of SDS 
bound Def-A. (A) Relative intensities and connectivities of NOEs and (B) Superposition 
of 10 lowest energy structures for SDS bound Def-A. Left panel: superposition of 
residues 1-27. Right panel: superposition of residues 27-38. The structures were 





 The surface diagram (Figure 3.11A) of Def-A shows clearly that the positively 
charged residues cluster in the C-terminal segment and the hydrophobic residues cluster 
in its long N-terminal segment. The rms deviations for N-terminal (Gly-1-Glu-27) and C-
terminal (Glu-27-Arg-38) segments were 0.39 and 0.17 Ǻ, respectively. Because there 
were no observable NOE restraints between the two segments, their relative positioning 
was quite poorly determined. Nevertheless, it is clear that the second helix bends towards 
the first one due to the presence of P25. Interestingly, the hydrophobic residues are 
distributed on one face of each helix while charged residues are on the other face. This 
distribution can enhance the interaction of the peptide with the micelle or with the 
bacterial membrane.  
The length of the N-terminal helix is 27 Å long and this helix can comfortably fit 
into the interior of SDS micelle which is of 40-50 Å in diameter (Hayter et al., 1981; 
Sheu et al., 1985; Itri et al., 1991). Therefore we propose that the first helix is located 
inside the micelle and interact with the micelle tails through hydrophobic interactions 
while the second helix is partially exposed to the outside of the micelle and interacts with 
the micelle head groups through charge-charge interactions (Figure 3.11B). This model is 
further supported by the amide H/D exchange data, i.e., residues I3, L6, Y9, Y10, A11, 
R12, R14, L21, V23 and L24 in the long helix had very slow H/D exchange rates (<2x10-
5 s-1) while all residues in the second helix had much larger H/D exchange rates. We 
could not exclude the possibility that the positive N-terminus of the peptide is outside the 
micelle, but the second and third residues (I2 and I3) should be inside to interact with the 
hydrophobic tail of SDS since they are hydrophobic and the amide proton of I3 is 
protected from exchange with solvent deuterons. Previous studies on reshuffling of the 
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disulfide bonds or mutating the cysteine residues of HBD-3 have revealed the followings: 
(a) upon subjecting to SDS micelles the wild type and any of its linear analogue show 
increases in helical content (Liu et al., 2008; Boniotto et al., 2003), (b) neither reduction 
nor interchange of disulfide bonds shows significant effect on the activity of HBD-3 (Wu 
et al., 2003), (c) linear analogues in which all cysteines are substituted by hydrophobic 
residues like Trp or Phe show comparable activity to the wild type but if substituted by 
Ala or Tyr the activity is decreased (Kluver et al., 2005 and Krishnakumari et al., 2003), 
(d) only the number and proper distribution of positively charged residues and 
hydrophobic residues determine the potency of the peptides (Kluver et al., 2005). Further, 
it has been shown that the specificity of HBD-3 is altered by mutations and the 
derivatives lose their preferential inhibition and become significantly more salt sensitive 
(Kluver et al., 2005). These results imply that detailed structural studies are important for 
understanding the mechanisms of HBD-3 and its analogues against microbes. 
 Although the 3D structure of HBD-3 in the presence of SDS (or membrane 
mimics) is not available, the overall structure should not be affected by SDS because the 
3 pairs of disulfide bonds in HBD-3 restrict its structural changes. A previous study using 
CD has demonstrated that the content of the β- conformation of HBD-3 remains unaltered 
though the α-helical content increases in the presence of SDS micelles (the N-terminal α-
helix could be longer in SDS) (Boniotto et al., 2003). Therefore, the HBD-3 structure in 
the absence of SDS can be approximated as the overall structural fold of HBD-3 in the 
presence of SDS. A structural comparison of HBD-3 and SDS bound Def-A shows that 
both have positively charged residues asymmetrically distributed in between their 
hydrophobic patches (Figures 3.11A and 3.11C). The presence of disulfide linkages in 
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HBD-3 leads to a more compact structure with one small and one large positively 
charged patches (patch 1: R14, R17, K26, R42, R43, K44 and K45; patch 2: K32, K36, 
R38 and K39). The charged patches are separated by one large hydrophobic patch. The 
residues in Def-A also form one small and one large positively charged patches (patch 1: 
K8, R12 and R17; patch 2: K32, R36, R38, K39, K40, R42, R43, K44 and K45). 
However, the two charge patches are located in two non-interacting helices. In addition, 
the hydrophobic patch is narrow and long for Def-A, rather than wide as for HBD-3. 
Since Def-A contains more hydrophobic and charged residues than HBD-3, it is indeed 
more potent than the reduced rHBD-3, but it is less potent than the wild type HBD-3 
(with disulfide bonds) against most bacterial strains at the same ionic strength. Thus, the 
significant difference in the distribution of charged residues and hydrophobic residues 
over the 3D structures can attribute to the differences in the activity and specificity of 
HBD-3 and Def-A. In addition, Def-A exists in a monomeric form since no 
intermolecular NOEs were observed. On the other hand, the wild type HBD-3 may exist 
in a dimeric form due to its unique 3D structure (Schibli et al., 2002). The dimeric form 
has a significantly higher positive net charge than the monomeric analogues. This may 
explain why the wild type is significantly less sensitive to salt concentration than its 
analogues in antimicrobial activity. According to our model (Figure 3.11B), mutations of 
non-hydrophobic residues in the first helix of a linear HBD-3 analogue to hydrophobic 
residues will enhance peptide-micelle (membrane) interactions and thus increase the 
activity of the peptide. This explains why the mutants with Cys to Ala and Tyr have 
significant lower activity than the mutants with Cys to Trp and Phe (Kluver et al., 2005; , 




Figure 3.11: Surface of Def-A and HBD-3. (A) Surface representations of Def-A 
showing the charge and hydrophobic clusters/patches. Positive charge patch 1: K8, R12 
and R17; patch 2: K32, R36, R38, K39, K40, R42, R43, K44 and K45. (B) A model 
showing the insertion of Def-A into the SDS micelle. The head groups of all SDS 
molecules are shown as spheres with red tinge and their aliphatic tail regions as straight 
lines. The diameter of SDS micelle is ~50Å and the length of the helical segment inside 
the micelle is ~27Å. (C) Surface representations of HBD-3 (1kj6.pdb) showing two 
positive charge patches. Patch 1: R14, R17, K26, R42, R43, K44 and K45; patch 2: K32, 
K36, R38 and K39. The surfaces were generated using Pymol 
(http://pymol.sourceforge.net/) and the colors used for representing the residue types are 
Blue: Positive charged residues (K and R); Pale yellow: hydrophobic residues (A, I, L, Y 
and V); Red: negative charged residues (E); and Grey: others (N, Q, S and T). 
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3.6 Backbone dynamics of Def-A. 
 To obtain the backbone dynamics of SDS bound Def-A, we measured the 15N 
relaxation rates R1 and R2 along with the {1H}-15N NOE (Figures 3.12A, B and C). In the 
first helical segment (Ile-3 to Leu-24) the average R2 and NOE values were 8.58 ± 1.04 s 
-1 and 0.52 ± 0.12, respectively, while in the  second helix (Glu-27 to Arg-38) they were 
6.84 ± 1.27 s-1 and 0.38 ± 0.09, respectively. On the other hand, R1 values were quite 
uniform over the entire sequence. The average order parameters for the first and second 
helices were 0.74 ± 0.05 and 0.64 ± 0.05, respectively, showing that the long helix is 
more rigid than the short one. The backbone flexibility indicates that the long helix is 
more restricted than the shorter one in motion, consistent with our model, i.e., the long 





















Figure 3.12: Relaxation data and order parameters of SDS bound Def-A.  
Longitudinal relaxation rates R1 (A), transverse relaxation rate R2 (B),  {1H}-15N 







 Def-A is a HBD-3 analogue that  contains no cysteine residues and has a very 
different 3D structure from HBD-3. Like most anti-microbial peptides, Def-A adopts a 
random coil conformation in aqueous solution and forms helical structures in membrane 
mimicking media. Def-A may target bacteria by approaching the cell surface through the 
electrostatic interaction and then further disrupting the membrane with the insertion of 
the long helix into the cell membrane wall. Although Def-A contains more positively 
charged residues and hydrophobic residues than HBD-3, it is active only at low ionic 
strength and hence should differ from the HBD-3’s mechanism of antimicrobial action. 
This indicates the significance of the 3D structural differences between Def-A and HBD-
3 in its antimicrobial activity. Further understanding of the interaction of HBD-3 with the 



















Lipid Specificities of ‘Def-A’ and the 











CHAPTER 4: Lipid Specificities of ‘Def-A’ and the Interaction of Def-A 
       with LPS 
 
 The potency of Def-A against both Gram-positive and Gram-negative bacteria has 
already been shown in section 3.2. As a continuation of our efforts to understand the 
relationship between the structure and modes of action of the HBD-3, we report the lipid 
specificities of Def-A in this chapter. In Gram-negative bacteria, the 
Lippopolysaccharide (LPS) molecules are considered to be the primary target for 
antimicrobial peptides, thus the analysis of specific interaction between LPS and Def-A is 
thought to be important to identify the sequences responsible for the binding and to 
design a peptide with improved specificity. The LPS binding affinity of Def-A and the 
structure of Def-A in complex with LPS are described in this chapter.  In addition, this 
chapter includes explanation for lipid specificity of Def-A where results obtained from 
the conformational studies of Def-A under different model mimicking agents are 
discussed. 
4.1 Lippopolysaccharide (LPS) Molecules of Gram Negative Bacteria 
 Unlike Gram-positive bacteria, the Gram-negative bacteria have an additional 
outer membrane which is predominantly composed of specific glycolipid molecules 
called Lippopolysaccharide (LPS) (Nikaido 1994). Each individual LPS molecule is 
made up of three distinct domains; the proximal hydrophobic lipid A, the distal highly 
variable polysaccharide moiety (O-antigens) and the core oligosaccharide region that 
covalently bridges the proximal and distal domains (Figure 4.1). LPS is highly conserved 
in all Gram-negative bacteria and contains six to seven fatty acyl chains per molecule 
connected by bis-phosphorylated di-glucosamine (Rietschel et al., 1993). A single cell of 
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E. coli is known to have around 106 lipid-A molecules as the integral component of its 
cell wall. LPS molecules also serve as a permeability barrier against the attack of 
antibiotics or antimicrobial peptides on the Gram-negative bacteria (Nikaido, 1994; 
Snyder et al., 2000 and Snyder et al., 1999). In fact, Gram-negative bacteria develop 
resistance or susceptibility towards the antibiotic agents by undergoing mutations in their 
LPS biosynthesis machinery (Hancock et al., 1984). In addition, LPS is known to provide 
a suitable environment for the correct folding of the outer membrane proteins (de Cock et 





















Figure 4.1: Chemical structure of LPS present in the outer membrane of the Gram-
negative bacteria depicting the outer core, inner core and Lipid A. (Figure adopted form 








4.2. The toxic nature of LPS; the need for their sequestration  
 LPS molecules help bacteria in diverse ways but are also constantly critically 
involved in human death and diseases. When infecting humans the Gram negative 
bacteria release a large number of LPS molecules into the blood stream. The 
concentration of LPS molecules are found to further increase if an intensive antimicrobial 
chemotherapy is carried out to kill these bacteria. When released in systemic circulation, 
LPS molecules are recognized by phagocytes, monocytes or macrophages of the innate 
immune system which in turn releases cytokines namely interleukins and necrosis 
factors-α as a common response to pathogenic invasion. These cytokines might causes 
damages in tissues and their excess production leads to various constellation symptoms 
like septic shocks, endothelial damages, loss of vascular tone, coagulopathy and multiple 
system organ failure leading to death. Reports show that sepsis is the major cause of 
mortality in ICU (Intensive Care Unit), which had lead to 600,000 deaths in United States 
alone (Martin et al., 2003). As it finally leads to sepsis or septic shocks, LPS is also 
named as endotoxins (Fink et al., 1990; Hardaway et al., 2000). The molecular level 
analysis of the same mechanism reveals the existence of so called Lipopolysaccharide 
binding proteins (LBP) that actually recognizes LPS and forms LPS/LBP complex. In 
turn these complexes are recognized by the toll like receptors that initiate the signaling 
cascades for the over production of inflammatory cytokines which leads to many 
potential problems.  
 Hence the root cause for these problems is the increased concentration of LPS 
molecules in blood stream. There are studies to generate therapeutic agents which not 
only kill the bacteria but also prevent the entry of LPS into blood stream. As mentioned 
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earlier, the increased release of LPS caused by the administration of antibiotics could 
even end up with death. The practice of using anti-endotoxic antibiotics for treating 
Gram-negative bacterial infections are thus considered to be very important. However, 
these bacteria have high tendency to develop resistances against these antibiotics. 
Antimicrobial peptides that can specifically bind and sequester these LPS and prevent 
immune responses are considered to be a promising  remedy for this problem. Peptides 
like human LL37, rabbit CAP18, sheep SAMP29, Polymyxin-B etc., are found to 
specifically bind with LPS molecules but when tested they are toxic to human cells too 
(Hirata et al., 1994; Tossi et al., 1994; Skerlavaj et al., 1996; Tack et al., 2002; larrick et 
al., 1995; Cowland et al., 1995; Gennaro et al., 2000; Durr et al., 2006; Zelezetsky et al., 
2006). So, a non-toxic antisepsis peptide which can block the LPS from interacting with 
the serum and cellular receptors is the final goal to fulfill the need of therapeutic 
applications.  
4.3. HBD-3 interacts specifically to LPS molecules 
 The binding specificity of HBD-3 to LPS isolated from different bacterial strains 
was studied by Bohling et al., 2006 through electrical measurements and HBD-3 induced 
lesion formations on LPS aggregates. Their in vitro experiments showed clearly that 
HBD-3 has specific binding to the LPS aggregates isolated from bacterial strains that are 
sensitive to HBD-3. While HBD-3 has no binding when the LPS molecules were isolated 
from the insensitive strains. The presence of a single positive charge on the LPS head 
group is enough to inhibit the HBD-3’s binding indicating the presence of electrostatic 
interaction. In principle, LPS are considered to be the primary target for most of the 
antimicrobial peptides. We tried to understand the mechanism of their actions by 
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studying the structure activity relationships. For structural analysis of the selective 
binding, we chose LPS from E. coli and attempted to determine the structure of LPS 
bound Def-A. Our study has two main motives: one is to determine the structural 
component involved in LPS binding and the other is to provide important information for 
the design of efficient non-toxic antisepsis peptides.  
 4.4 Isothermal Titration Calorimetric studies for binding of Def-A with LPS  
 The ITC studies for Def-A binding with LPS aggregates reveals that the 
interaction depends highly on the molar concentrations ratio of both species. The 
thermogram and heat generated spikes in figure 4.2 shows that when a high concentration 
of peptide (0.5 mM Def-A) was titrated into the LPS solution (0.05 mM), there occurs 
more than one type of binding curve; the initial binding saturates within four injections of 
the peptide solution (corresponding to a total of 34 µL) and the later shows a strong 
binding that saturates after 26 injections (corresponding to 254 µL of Def-A). The 
concentration at which the first saturation occurs is less than 0.1 mM of Def-A. This 
observation is validated by performing separate titration experiment using 0.1 mM of 
Def-A as the titrant (figure 4.2 B) and the thermogram shows only one binding saturation. 
Even though we can clearly assume a micromolar binding, the exact thermodynamic 
parameters could not be determined due to the multiple binding processes. 
 As LPS molecules are known to form aggregates in solution at concentrations ~14 
- 20 µg/mL (Santos et al., 2003) and are heterogeneous in solution, their exact 
concentrations are generally expressed in weight per milliliter (Raetz et al., 2002). The 
saturation of the binding curves revealed that Def-A binds with LPS aggregates and the 
concentration dependency confirmed the existence of more than one type of binding 
89 
 
mechanism for Def-A. The heat generated spikes obtained upon each injection shows that 
the binding is purely exothermic but there could also be some endothermic 
binding/stabilization processes during the binding process. Even though this unusual 
behavior of Def-A binding with LPS aggregates was initially thought to be artifacts, later 
repetition of results in different machines (data not shown) proved that the data are valid. 
 
 
Figure 4.2: Isothermal calorimetric titrations for the binding of Def-A to LPS 
aggregates. ITC experiments were carried out in 10 mM sodium phosphate buffer, pH 
7.4 at 25 °C. (A) Injection of 10 µL aliquots containing 0.5 mM Def-A into a solution of 
50 µM LPS aggregates 10 mM phosphate buffer at pH 7.4 resulting in the spikes, 
reflecting the heat change upon each addition. (B) Injection of 10 µL aliquots containing 
0.1 mM Def-A into a solution of 50 µM LPS aggregates 10 mM phosphate buffer at pH 





4.5 Tr-NOE derived solution structure of Def-A bound to LPS 
 As the interaction of LPS with Def-A is expected to enhance the formation of an 
ordered structure in the peptide, thus of the exact LPS interacting region of the peptide is 
determined by solution NMR studies. Def-A, when bound to LPS aggregates, behaves 
like a very large molecule, making the solution structure determination very difficult. 
Thus tr-NOE generated signals were utilized to determine the structure of Def-A bound 
to Def-A. This technique is generally used to determine the structure of a ligand when it 
is bound to a large macromolecule with considerably low affinity (~ µM Kd) and exists in 
fast equilibrium (NMR time scale) between the free and bound states. This fast transition 
is able to transfer the NOE signals from the bound state to the free state. For this purpose, 
the ratio of the ligand to macromolecule is maintained such that only a small population 
of the peptide is bound to the macromolecule and cannot be detected directly but transfers 
its signal to the free ligand to determine the bound structure. LPS molecules form large 
aggregates at concentrations above 40 µM and behave as macromolecule to allow the 
observation of tr-NOE cross-peaks from the bound peptides. The use of Tr-NOE for 
solving the structure of LPS bound peptides has been shown by many other researchers 
(Bhattacharjya et al., 1997 and 2007; Japelj et al., 2005).  
 Initially, a series of 1H-NMR spectra was recorded for a solution of 0.3 mM of 
peptide by titrating it with increasing amounts of LPS. The observation of the signal 
broadening in 1H-NMR without any significant change in the chemical shift showed the 
existence of fast equilibrium between free and the LPS bound Def-A. The ligand to 
macromolecule ratio was chosen at a point when nearly all the signals got broadened and 
the sample remained stable over the period of NMR data collection. 15N-edited NOESY-
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HSQC and 15N-edited TOCSY-HSQC spectra recorded for the free peptide were utilized 
to perform the sequence specific assignments. The NOESY for the free peptide had only 
intra-residue and sequential NOEs between the backbone and side chain proton 
resonances showing that Def-A is highly flexible and it does not adopt any stable 
conformation in the free state. The conformational stabilization of the peptide in the 
presence of LPS was observed through the ample increase of backbone and side chain 
resonances (Figure 4.3). 
 The structure calculation was based on the cross peak intensities in the tr-NOESY 
spectrum at a mixing time of 150 ms. No dihedral angle or hydrogen bonding restraint 
was used in the structure calculation. In total, only 390 unambiguous distant restraints 
were used for the calculation. For each cycle, one hundred structures was calculated 
using CYANA 1.1 and finally 10 lowest energy structures were considered for further 
analysis. The distance restraints were adjusted as per the NOE violations for further 
structure refinement. After final refinement, most region of the peptide was found not to 
adopt any regular secondary structures while 15 out of the 45 residues converges into a 












Figure 4.3: The 1H-NMR of Def-A’s amide region shows the signal broadening before 
(red) and after the (green) addition of LPS, and the representative slices of the 3D Tr-
NOESYspectrums showing the tr-NOE generated peaks (Panels A, C, E, G and I showing 
the NOESY before addition and the panels B, D, F, G, H and J shows the tr-NOEs 












Figure 4.4: The solution structure of LPS bound Def-A. (A) Primary sequence of Def-
A with the structured region shown in large italic font. (B) Superposition of 10 lowest 
energy structures (residues 20-35) for LPS bound Def-A. The structures were generated 
using Molmol (Koradi et al, 1996). (C) Structure of the LPS molecule showing the 
presence of phosphate groups and hydrophobic tail region. (D) Surface representations of 
Def-A showing the charge and hydrophobic clusters/patches. Surfaces were generated 
using Pymol (http://pymol.sourceforge.net/) and the colors used for representing the 
residue types are Blue: Positive charged residues (K and R); Pale yellow: hydrophobic 
residues (A, I, L, Y and V); Red: negative charged residues (E); and Grey: others (N, Q, 
S and T). 
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 The structure of the LPS bound Def-A authenticates that the possible LPS 
interacting region in the Def-A sequence lies between residues Val 20 to Arg 36. The 
amphipathic structure of Def-A (Figure 4.4) indicates that the positive charge patches at 
both the N and C terminal ends of the peptide segment are the possible binding sites to 
interact with negatively charged phosphate groups of LPS molecule (which are nearly 14 
Å apart) while the helical element present in the converged region binds to the acyl side 
chains of the LPS molecule. This is speculated from the phenomenon that the formations 
of helical structure in peptides are most likely due to their hydrophobic interactions with 
that of the bio or model membranes. These kinds of partial helical structures are believed 
to have consequences in crossing the outer membrane barrier of Gram-negative bacteria 
(Papo et al., 2005; Porcelli et al., 2008). Peptides like melittin (Bhunia et al., 2007) are 
proposed to have partially ordered conformation located on the outer membrane surface 
that can facilitate their efficient translocation. The LPS bound structure is very different 
to that of the SDS bound peptide (Figure 3.10) which indicates two things 1) the peptide 
adopts different structures in different environments and 2) the basic understanding of 
peptide interactions with the bacterial membranes is very important for design of peptides 
with therapeutic values. Our LPS bound peptide structure can thus pave the way for the 
further study in development of potent peptides which can specifically sequester the LPS 
molecules. 
4.6 Proposed model of Def-A/LPS complex 
 
 The mode of bound of Def- A on the LPS molecules was obtained by docking of 
the transfer NOE generated structure of Def-A with the LPS molecule. The docked model 
(Figure 4.5) reveals that the Def-A/LPS complex is stabilized by the amphipathic nature 
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of Def-A that allows a number of possible interactions like hydrogen bonding, 
hydrophobic and salt bridges within the glucosamine I and glucosamine II moiety of LPS 
molecule. The flexible nature of Def-A allows it to firmly coil around the lipid A moiety 
of LPS molecule through several packing interactions. The residues Gln 29, Gly 31, Val 
33 and Arg 36 involves in hydrogen bonding with the H1 atom while Ser 34 shows 
bonding interactions with the HG1 atom of the glucosamine. The VDW interactions are 
also seen between the Lipid A molecule and the Tyr-18 and Glu 28 amino acids of Def-A.  








Figure 4.5: Proposed model of the LPS/Def-A complex. The figure depicts the  
plausible interactions between the amino acid residues of Def-A (thick lines) and the lipid 




4.7 Detergents and lipids used for the study 
 In order to check whether the peptide can discriminate among different types of 
membranes, we investigated the interaction of Def-A with several model membranes. For 
the entire study, different types of lipids and detergent molecules were chosen (Figure 
4.7) and the secondary conformational changes of Def-A were analyzed in all these 
molecules through CD spectral studies. As LPS forms large aggregates and give strong 
background it became impossible to record CD spectrum for LPS bound Def-A. The 
choice of the lipids and detergent molecules were as described below: POPG and SDS 
were chosen as they possess negatively charged head groups with hydrophobic tails and 
can mimic the outer membranes of Gram-negative bacteria when they get arranged as 
vesicles or micelles in solution (Chapter 3 has already analyzed in detail), POPC and 
DPC molecules were chosen due to their zwitterionic head groups and hydrophobic tail 
regions, mimicking the outer membrane of mammalian cells when forming vesicles or 
micelles. As mentioned earlier, the choice of LPS molecules has two major reasons, (1), 
they are considered to the primary targets when an AMP invades a Gram-negative 
bacterium, and (2), sequestration of these LPS molecules are considered to be important 
in the design of a peptide with anti-inflammatory properties. Finally, the helix inducing 
organic solvent TFE was chosen to check how well Def-A can adopt helical 
conformation and to monitor smoothness of transition. 
4.7.1 Comparison between SDS micelle and POPG vesicles 
 Unlike the vesicles, the micelle formations by SDS and DPC occur when their 
concentrations are just above their critical micelle concentration (CMC) values (Table 
4.1). The size of the micelles and number of molecules in the micelles depend on the 
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concentration, salt and pH of the medium used (Rahman et al., 1983). In our 
experimental conditions the diameter of SDS and DPC micelles should be from ~40-50 
Å, whereas the diameters of POPG and POPC vesicles were either 500 Å (SUV) or 1000 
Å (LUV). The large unilamellar vesicles (LUVs) were prepared from the multilamellar 
vesicles by extruding them using 100 nm pore size filters (Section 2.5.1).  The sizes of 
the prepared POPG and POPC vesicles were tested using dynamic light scattering (DLS) 
experiments (Figure 4.6 a and b). The histograms show the size distribution for both the 
liposomes and the measured average radii are 46.4 nm and 44 nm for POPG and POPC 
vesicles respectively.   
 
 













Figure 4.6b: Dynamic Light Scattering (DLS) results for POPC vesicles.    
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Figure 4.7: Chemical Structures of all the molecules and models used for mimicking the 
bacterial and mammalian cell membranes. The size comparison for SDS micelles (top 
left) and POPG vesicles (top right) is shown 
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4.7.2 Preferential binding of Def-A towards lipids 
 Some aspects of the secondary conformational changes occurring when Def-A 
bound to different membrane models have already been discussed in the previous 
chapter. Here we give more insights into the lipid specificity of Def-A. The linear peptide 
under different conditions gives rise to different CD spectra (Figure 4.8A) which 
confirms that the conformations are strongly influenced by the environment. The nature 
of Def-A to human is also confirmed by its unaltered secondary conformation in the 
presence of POPC vesicles that mimics zwitterionic mammalian cells.  
 Noticeably, the secondary structures of Def-A in SDS and DPC micelles are very 
similar, whereas it shows difference for their vesicle counterparts (POPG and POPC). 
DPC micelles are commonly used as a membrane mimics to study the three dimensional 
structure of the AMPs (Porcelli et al., 2004; Porcelli et al., 2006; Campagna et al., 2007; 
Ovchinnikova et al., 2007; Powers et al., 2005; Hicks et al., 2003; Javadpour et al., 1997; 
Gesell et al., 1997; Park et al., 2002; Rozek et al., 2000; Roumestand et al., 1998). It is 
considered that initial binding interactions are purely electrostatic and bound the 
peptide’s conformation changes to helix due to hydrophobic interactions. It is obvious 
that the depletion of membrane is necessary for this hydrophobic interaction. When Def-
A was treated with POPC vesicles we do not see any conformational change in the CD 
spectrum which clearly says that Def-A might not have depleted the POPC vesicle. This 




Figure 4.8: Circular Dichroism spectra of Def-A under different conditions. (A) The 
far-UV CD spectra of 20 µM Def-A recorded in 10 mM phosphate buffer (- ·· -), plus 50% 
TFE (····), 20 mM micelles of DPC (-) and SDS (- - -), 1 mM POPC (---) and 1 mM 
POPG vesicles (- · -). (B) Structural transition of Def-A when the concentration of TFE 
is increased from 10% to 90%. The insert shows the change of the ellipticity at 222nm 





 TFE titration was done to monitor the conformational transition in Def-A, here we 
show that intermediate was formed during the conversion from random coils to helical 
like structure. The existence of a well-defined isodichroic point (Figure 4.8 B) indicates 
that only two conformational states are in equilibrium (random coil and a-helix). The 
ability of a peptide to adapt to the membrane environments is considered essential for a 
peptide to be more potent and less toxic. 
 Here, it has been determined that Def-A selectively binds to POPG, LPS and SDS 
molecules and does not bind to POPC vesicles. After solving the structures of LPS and 
SDS bound peptide, it will be interesting to have a POPG bound peptide structure. 
However due to the large size of these vesicles, classical NMR methods are not suitable. 
On the other hand, as ITC data shows that Def-A has a strong affinity (nanomolar range) 
towards POPG vesicles, so tr-NOE experiment may not be feasible. In fact, several 
NOESY spectra, obtained by mixing 15% (w/w) POPG vesicles to the peptide, were 



























CHAPTER 5: Conclusion and Future Work 
 Human Beta Defensin - 3 (HBD-3) is considered to exhibit many interesting 
features which includes unusual high positive charge (+11), broad spectrum of activity, 
relatively insensitive to high salt concentration (Harder et al., 2001). It also holds very 
low lytic activity on the human erythrocytes with no cytotoxic effect against human cells 
(Harder et al., 2001). Along with HBD-3, the three dimensional structures of a number of 
other defensins have also been determined by NMR and X-ray spectroscopy (Hoover et 
al., 2000 and 2001; Schibli et al., 2002; Hill et al., 1991; Szyk et al., 2006).  Several 
investigations show that HBD-3 is active against E. coli, P. aeruginos, K. pneumonia, 
Staphylococcus aureus, Streptococcus pyogenes, E. faecium, S. pneumoniae, 
Staphylococcus carnosus, and many others (Harder et al., 2001; Hoover et al., 2003; Wu 
et al., 2003; Shelburne et al., 2005; Starner et al., 2005). Even though it is highly potent 
to many strains, some strains like Burkholderia are known to be highly resistant to HBD-
3 (Sahly et al., 2003). This shows that HBD-3 is not only potent but also relatively 
selective. Previous studies demonstrate that the membrane induced helix in HBD-3 might 
be important for its selection of bacterial membranes (Morgera et al., 2008). On the other 
hand, the activity and cytotoxicity of HBD-3 depend on its overall positive charge 
distribution and the hydrophobicity. For various beta defensins including HBD-3, the 
presence and position of S-S bonds and N-terminal sequence variation seem to have only 
a marginal effect on their activities (Kluver et al., 2005; Wu et al., 2003; Morgera et al., 
2008; Mandal et al., 2002; Krishnakumari et al., 2003). In contrast to the antimicrobial 
effect, the chemotactic mediated activity is clearly susceptible to changes in S-S 
arrangement (Wu et al., 2003). The activity of HBD-3 is confined with its lipid 
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specificity and thus HBD-3 is more selective against certain strains and safe on 
mammalian cells (Bohling et al. 2006). Although there are many findings on various 
aspects of HBD-3 (Dhople et al. 2006), the structure-activity relationship still remains 
largely unknown. 
 Series of studies by other people have proven that the high cationic charge of the 
peptide plays a major role rather than the disulfide connectivity or secondary structure of 
peptide, either α - helix or β - sheet. As fragment with high charge is more potent than the 
other segments, it leads us to express peptides without S-S connectivity but with different 
charge. Now we are in the process of expressing the wild type HBD-3 in E. coli and also 
mutated analogues having one, two and three disulfide linkages to do further study.   
 Our work has clearly shown that unlike the wild type HBD-3, Def-A is salt 
sensitive in activity but has high activity against the tested strains in the absence of salt. 
The binding of Def-A depends on both the outer charge of the model membrane and also 
the chemical nature and arrangement. The SDS bound structure suggests that the peptide 
should adopt complete helical arrangement when interacting with the Gram-positive 
bacteria. While the LPS bound structure of Def-A suggests that the peptide might 
preferentially bind to the LPS molecules present in the outer membrane of Gram-negative 
bacteria. The linear nature of Def-A allows a smooth transition from random coil state to 
helical structure. Through the ITC binding studies we show that Def-A has higher 
binding capacity towards the POPG vesicles than the LPS aggregates. The major 
difference between Def-A and HBD-3 is the three dimensional structure due to the three 




 Even though we have analyzed the Def-A behavior by considering various aspects, 
we lack experimental information regarding how the structurally folded wild type HBD-3 
interacts in similar conditions. In fact, we could not study the direct properties of wild 
type HBD-3 because we faced several problems in expressing the wild type HBD-3 in its 
correctly folded form or oxidize the rHBD-3. Hence the future of this research should be 
focused on experimenting the native peptide’s properties to find out the direct structure-
function evidence for the activity mechanism of HBD-3. Designing several other 
analogues with mutations at positions other than the cysteine residues can be considered 
to localize the direct interaction or importance of any specific region in their activities.  
 Though model membranes are considered to mimic the real membranes, they are 
mere speculations. Real biological membranes are very complicate in their composition 
when compared to any membrane mimicking medium. As they are comparable in charge 
and hydrophobicity, the study of interaction of antimicrobial peptide with model 
membranes is very common in terms of their efficiency. But in order to determine the 
behavior of peptides or proteins when they are inside a cell, the In-cell NMR techniques 
(Serber et al., 2001) are currently used and have gained much interest among the 
researchers. It remains to be discovered on how an antimicrobial peptide selects the 
pathogen and what is the mechanism lying behind their entry into the membrane to carry 
out their activities. Hence, in vivo NMR method can really help one to analyze the 
structure based mechanism of action for any antimicrobial peptide and to extend their 
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